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General introduction
This chapter contains modifi cations of the following publications:
R.C. Hoogeveen, G.C.H. Sanderink, and W.E.R. Berkhout
Effect of head position on cephalometric evaluation 
of the soft tissue facial profi le 
In Dentomaxillofacial Radiology 2013; 42: 20120423 
and
R.C. Hoogeveen en G.J.M.C. van den Aardweg
Radiobiologische aspecten van tandheelkundige röntgendiagnostiek
In Nederlands Tijdschrift voor Tandheelkunde 2015; 122: 2015.05.14223
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The discovery of X-rays by W.C. Röntgen on the 8th of 
November 1895 was an important event in the medical 
history. The dental profession was quick to recognize the 
possibilities for the use of X-Ray imaging. Shortly after 
Röntgens publication entitled ‘Über eine neue Art von 
Strahlen’,1 the first dental application of these rays was 
demonstrated by German dentist O. Walkhoff in collaboration 
with professor F. Giesel. Two intra-oral images are preserved 
that were captured on glass photographic plate after an 
exposure time of 25 minutes per image. The interest for the 
use of X-rays was enormous and the news of this discovery 
travelled fast across the world by telegraph cable. Within a 
few months the American dentist W.J. Morton published an 
article about the possibilities of the use of X-rays in dentistry 
in the then leading scientific journal the Dental Cosmos in 
June 1896.2
With the introduction of the use of X-rays in dentistry as a diagnostic tool, 
understanding of the pathophysiology of dental disease and of oro-facial 
developmental anomalies expanded greatly. Just prior the discovery of X-rays, 
orthodontics had only just begun to emerge as a specialty3 and the new 
diagnostic technique of ‘orthodontic radiology’ was soon integrated into this 
branch of dentistry.4 
ORTHODONTIC RADIOLOGY 
Today, the diagnostic information provided by orthodontic radiography 
can assist in the staging of the development of dentition, the diagnosis of 
eruption problems, the visualisation of deviations in the number and the form 
of the teeth, as well as by excluding the presence of pathology. The earliest 
exposure techniques in use in dental radiology were projection images made 
with intra-oral film techniques, and extra-oral film techniques such as oblique 
lateral views. To acquire panoramic images of complete dental arches, various 
approaches were explored. In 1943 German inventor Horst Berger developed 
an ‘inside out’ technique with the source of X-rays placed intra-orally and the 
film placed extra-orally, moulded to the patient’s face.5 This technique was 
superseded however by the technique of orthopantomography. Made possible 
by the introduction of tomographic techniques by B. Ziedses de Plantes in 
1932, orthopantomography was developed by Y.V. Paatero in 1958 to enable 
an overview of the complete dentition to be obtained with one exposure.6,7 
Improvements in orthopantomography over the following 60 years such 
as improved image quality, reduced distortion and a much lower radiation 
dose mean that orthopantomography is the most widespread radiographic 
orthodontic diagnosis technique in use today. 
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Another, more recently developed, radiographic technique for diagnosing 
dental pathology and developmental disturbances is cone beam CT (CBCT). 
This three dimensional X-ray technique also found a place in orthodontic 
radiology for diagnosing specific problems that require evaluation of spatial 
relationships.8 However due to its higher patient radiation dose compared 
to conventional techniques, CBCT is not the modality of choice for general 
orthodontic diagnosis.
DIAGNOSIS OF CRANIOFACOAL GROWTH 
Orthodontists are concerned with diagnosing orthodontic deviations and 
pathology in dental arches, and they are also concerned with the relation of 
the dental arches to the jaws, and the jaws in relation to the skull base and 
the face. In 1904 the first lateral cephalogram made for orthodontic diagnosis 
was published by M.H. Creyer in The Dental Cosmos.9 It took a relatively 
long time however for the lateral cephalogram (Ceph) to become established 
in orthodontic radiology. This was perhaps because E.H. Angle, the man 
considered by many to be the ‘father of orthodontics’, did not see a need for 
cephalometry in orthodontics at the time. He believed he could treat occlusion 
very well without the need for diagnostic information about facial growth and 
maxillofacial relationships.10 In 1932 both O.D.H. Hofrath in Germany and B.H. 
Broadbent, Jr. in the U.S.A independently arrived at concepts of standardising 
the Ceph.11,12 The use of a cephalostat, a head-positioning device created by 
Broadbent, together with his idea of aiming the central ray through the left 
and right external auditory meatus and with the Frankfurt Horizontal plane of 
the subject parallel to the floor, remains basically the means by which a Ceph 
is now produced.13 This standardisation made it possible to analyse facial 
morphology, facial growth and orthodontic and surgical treatment effects of 
subjects over time. 
ORTHODONTIC CEPHALOMETRY
Longitudinal prospective series of Cephs of larger groups of individuals have 
improved our understanding of facial development.14 The work of A. Björk, 
based on sequences of Cephs of growing individuals implanted with small 
metallic markers in their jaw bones, gave rise to paradigm-shifting insight 
in facial growth through translation, rotation and remodelling of the facial 
bones.15,16 In 1942 W.B. Downs published a system of cephalometric analysis 
of Cephs.17 It consisted of a series of measurements of angles and distances 
between lines drawn through cephalometric landmarks on the Ceph. In the 
decades following, C.C. Steiner, C.H. Tweed, A. Jacobsen and J.A. McNamara, 
Jr. among many others, also published their cephalometric analyses and 
norm values.18,19,20,21 The cephalometric diagnosis assists in decisions on 
appropriate treatment, for example in deciding on extraction versus non-
extraction therapy or in choosing which jaw should be influenced to correct 
a malrelation.22,23 A limitation of lateral cephalography however is that it 
is a two-dimensional projection image. As early as 1915, J.A.W. van Loon 
published his method for a three-dimensional analysis of the dentition in the 
face with his cubus craniophorus.24 This laborious technique involved taking an 
impression of the face and then a transfer of the position of the teeth into the 
plaster cast of the face for comparison. Another method used to explore the 
third dimension was with an antero-posterior cephalogram. This also involved 
the use of cephalometric analysis and norms.  
10    –    CHAPTER 1
When in the 1970s computed tomography (CT) scanning was introduced, high 
costs and high radiation doses initially prevented its widespread adoption 
in dento-maxillofacial radiology, including orthodontic cephalometry. From 
the beginning of the 21st century, however, cone beam CT (CBCT) became 
available with lower costs and lower radiation doses. The use of CBCT in 
orthodontics for cephalometric analysis then spread.25 However, because of 
its much higher X-ray doses, large volume CBCT for cephalometry is now only 
indicated in selected cases, for example involving asymmetries, cleft patients 
and orthognathic surgical planning.26 
The Ceph and cephalometric analysis is currently seen as an integral part of 
the orthodontic diagnostic preparation for treatment planning.27,28 Guidelines 
are not unanimous on the indications for use of lateral cephalograms in 
orthodontic treatment,29,30,31 and research findings are contradictory as to 
whether it is a necessity in orthodontic treatment planning.32,33,34 Nonetheless 
in practice lateral cephalography usually plays an integral part in orthodontic 
diagnostics.35 In the Western world, a high percentage i.e. 30% to 60% 
of children undergo orthodontic treatment.36,37,38 Other researchers have 
reported that 1% of the population undergoes orthodontic treatment 
annually.39 Millions of Cephs are therefore performed worldwide each year for 
orthodontic diagnosis. 
The radiation dose administered per Ceph has decreased dramatically since 
the early days of cephalography. The development of films with higher 
sensitivity, of intensifying screens, and later of digital sensors and automatic 
exposure control, has brought the current radiation dose down to less than 
a tenth of those doses that were administered in the 1950s.40,41 Nevertheless 
the high frequency with which lateral cephalography is performed results in a 
considerable collective X-ray burden for the (on average) young population of 
orthodontic patients. 
RISKS OF X-RAYS
Shortly after the introduction of X-rays in medical and dental diagnostic 
applications, it became clear that there are risks involved for both the 
clinician and the patient. In 1928 the ‘International X-ray & Radium Protection 
Committee’ (IXRCP) was founded in Stockholm, Sweden, at the second 
International Congress of Radiology. The IXRCP was the predecessor 
of the current authoritative organisation, the ‘International Commission 
on Radiological Protection’ (ICRP).42 With its recommendations, reports, 
publications and guidance, this organisation exerts a worldwide influence on 
policies concerning radiological protection. 
Since its foundation, knowledge of the interaction between radiation and 
living tissues has increased enormously. An important advance was the division 
made between deterministic, hereditary and stochastic effects of radiation. 
Deterministic effects are induced by relatively high doses of radiation, and 
are the consequences of cell death or cell sterilisation. Depending on the 
rate of turnover of the tissues involved, they occur soon after irradiation 
has taken place.43 Deterministic effects will affect every individual when a 
threshold dosage is reached.44 The severity of the effects is related to the 
dose delivered. Hereditary effects can be caused by doses to the gonads. 
For dento-maxillofacial diagnostic X-ray exposures, these deterministic and 
hereditary effects are not relevant because the X-ray burden stays well below 
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threshold levels and because the gonads are not exposed.45 
Stochastic effects are long-term effects of radiation in the form of cancers 
which are caused through damage to the DNA. The chance of a stochastic 
effect occurring is related to the accumulated received radiation dose. So even 
if the dose is low, as in diagnostic dental radiology for example, it is important 
to consider stochastic effects. 
One of the most valuable sources of knowledge on stochastic effects of 
radiation is the Life Span Study (LSS), consisting of epidemiological research 
undertaken over decades on the survivors of the 1945 atomic bomb attacks on 
Hiroshima and Nagasaki in Japan.46 During this study, data were systematically 
collected on the medical histories of survivors, grouped according to the 
received dose during the (morally questionable) nuclear bombing of these 
two highly populated urban areas. The analysis of the study data revealed a 
dose-dependent effect, where some tissues or organs were more susceptible 
to radiation-induced cancer than other tissues. On the basis of the conclusions 
of the LSS and other research, the ICRP has arrived at a system of calculating 
stochastic effects called the ‘effective dose’.47 This system is based on the 
amount of energy deposited by radiation exposure in the tissues, where the 
unit is the ‘gray’ (symbol Gy) which corresponds to one joule of radiation 
energy per kg. This value in gray is corrected for the type of radiation and the 
type of tissue, after which it is expressed in the unit Sievert (Sv).44 The effective 
dose is not a direct measurable quantity, but rather has to be calculated on 
the basis of dose measurements on different locations during experimental 
exposures of phantoms or with the aid of computer simulated exposures of 
virtual phantoms. The ICRP has defined the relation between the dose and the 
risk of a stochastic effect by a risk factor which is 5%/Sv for an average person 
of 30 years of age. Children are more radiosensitive, and therefore their risk 
factor is higher, and females have a higher risk factor than men (see Fig 1). 
Figure 1 – 
Relation between age of exposure and the 
risk factor. Dotted line for females, dashed 
for males. Adapted from ICRP publication 
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This extra risk of experiencing a fatal radiation-induced cancer expresses 
itself after a period of latency. This latency period is, for thyroid cancer and 
leukaemia, around 6 years, while for other solid tumours it is around 20 years.45 
Following this latency period, in an irradiated population, the existing pattern 
of prevalence of cancer is multiplied by a (small) factor,42 with the endemic 
pattern showing a rise in  incidence of cancer after the sixth decade of life. 
In other words, the extra cancer incidence caused by stochastic effects due to 
radiation exposure is only noticeable after the sixth decade of life. This implies 
that generally a long period exists between an irradiation event and 
a consequential stochastic effect.
The nature of a stochastic risk is that, although it can be small, it increases 
linearly with the number of times the risk is run. This means that, although 
the dose and consequently the risk in a diagnostic exposure is small for an 
individual patient, when a population is exposed frequently, as has been 
shown to be the case with the frequent use of orthodontic Cephs in the 
population, stochastic effects will occur. 
REDUCING RISKS OF X-RAYS 
To minimise the stochastic risks incurred through diagnostic patient exposures, 
the ICRP has formulated radiation protection principles.45 The first principle is 
one of justification, that is, the benefit of the application of ionizing radiation 
needs to outweigh its hazardous effects. For diagnostic exposures, for every 
individual patient, the benefits must be balanced against the risks. A second 
important principle is that when the exposure is justified, this exposure 
should be executed with a dose to the patient that is ‘as low as reasonably 
achievable’; which is usually referred to as the ‘ALARA principle’.48 To achieve 
the ALARA principle, clinicians should use individualised minimised exposure 
parameters, such as the exposure time, the tube current and the tube voltage, 
in combination with the use of image receptors with high sensitivity. In this 
respect the clinician should also consider the image quality that is desired 
for the purpose of diagnosis. If noisier images are adequate for a correct 
diagnosis, then lower exposure settings are indicated. Finally, the field of 
the exposure should be limited to the area of interest, to avoid unnecessary 
irradiation of tissues. Special attention in this regard should be given to the 
thyroid gland which is the most radiosensitive organ in the head and neck 
region.49,50 Clinical guidelines urge the clinician to prevent exposure of this 
organ with the primary (image forming) X-ray beam.30,48 Hence, in lateral 
cephalography the use of thyroid collars containing a protective layer of 
X-ray attenuating material is indicated, except where it prevents a successful 
diagnosis being obtained.30,48 Despite these guidelines however, thyroid collars 
are not frequently used for lateral cephalography.51 P. Hujoel assumes that this 
is the case because clinicians desire the depiction of the cervical vertebrae 
in order to perform a maturation index to help the timing of orthodontic 
treatment in growing children.52
In applying the ALARA principle to lateral cephalography, besides the 
application of individualised exposure settings, reducing the field of view 
to the region of interest is also of importance. A number of researchers 
have proposed ways to reduce the field above the skull base and below 
the mandible where the thyroid is located.53,54,55,56,57,58 Their work has not 
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yet resulted in any practical application in current orthodontic radiological 
practice, however. In Chapter 2 of this thesis the design process of a novel 
device to collimate the field of view in the cranial area is presented. This 
chapter addresses the question of how this collimator should be designed to 
collimate as much as possible without affecting the diagnostic value of the 
exposure. In chapter 3, research is presented in which this novel anatomical 
cranial collimator (ACC) indeed does not interfere with the diagnostic process. 
In a validation study we tested if lateral cephalograms made with ACC present 
indeed did not hamper the diagnostic process. In Chapter 4 a novel thyroid 
protector is described which aims to shield the thyroid from the primary beam 
while leaving the cervical vertebrae depicted. A question that is addressed 
in this research paper is: how much dose reduction can the anatomical 
cranial collimator (ACC) and cephalographic thyroid protector (CTP) 
achieve? In undertaking this research we encountered the phenomenon that 
published dose studies do not contain credible confidence intervals for dose 
measurements. We have attempted to address this with the use of statistical 
software. In Chapter 5 a study is presented to investigate whether this method 
of correctly assessing random error with the use of software error simulation is 
indeed viable.
The dose of a lateral cephalogram can be considered to be low. To reduce 
this dose even further with the use of these devices brings costs for the 
clinician however. The ALARA principle implies that a proposed reduction 
should be achievable at reasonable cost. Determining what is ‘reasonable’ is 
an issue that so far has not been addressed in (dental) radiology. In Chapter 
6 different possible ways of performing the cost utility analysis (CUA) of dose 
reduction are compared. The question is, which method is best suited to 
resolve this issue in diagnostic radiology? The CUA methods are compared by 
applying them to two dose reducing measures. One of these measures is the 
use of the ACC and CTP in lateral cephalography. Therefore, this study also 
addresses the question of whether the use of these devices is beneficial when 
investigated with a CUA. In Chapter 7 the conclusions of the research are 
discussed with concluding remarks.
Justification: the benefit of application 
of ionizing radiation needs to outweigh 
its hazardous effects
The ALARA principle: when an exposure 
is justified it should be executed with 
a dose to the patient that is ‘as low as 
reasonably achievable’
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SAMENVATTING HOOFDSTUK 1 
ALGEMENE INTRODUCTIE
De ontdekking van röntgenstraling 
in 1895 had al snel grote invloed op 
de tandheelkunde. Röntgenstraling 
bracht veel meer begrip over het 
verloop van ziekten aan het gebit. 
Met de nieuwe techniek nam ook de 
kennis over groei en ontwikkeling 
van het aangezicht toe, evenals 
het ontstaan van afwijkingen in 
groei en ontwikkeling. Ook in het 
toen nog prille vakgebied van de 
orthodontie drong het gebruik van 
röntgenstraling door. Zo werden 
met projectie-opnamen afwijkingen 
in de kaakwallen opgespoord. Later 
werden panoramische tomografische 
technieken ontwikkeld die in één keer 
het hele gebit konden afbeelden. 
Deze panoramaopnamen worden 
nog steeds veel gebruikt in de 
orthodontie. 
Naast afwijkingen in de kaakwallen 
is de positie van de tandbogen ten 
opzichte van elkaar en ten opzichte 
van de schedelbasis belangrijke 
informatie voor de orthodontist. 
Al in 1904 werd hiervoor de eerste 
röntgenschedelprofiel-opname 
(RSP) gemaakt. In de jaren dertig 
van de vorige eeuw werd deze 
opnametechniek gestandaardiseerd, 
waarmee het mogelijk werd om 
verschillende opnamen van één 
individu met elkaar te vergelijken. 
In de decennia daarna werden 
zogenaamde cephalometrische 
analyses ontwikkeld om 
orthodontische behandelingen 
te plannen en de groei en 
behandelresultaten te evalueren. 
Hiervoor wordt op een RSP een serie 
oriëntatiepunten gemarkeerd. Door 
deze punten te verbinden met lijnen 
en vervolgens hoeken en afstanden 
te meten, zijn de anatomische 
verhoudingen te vergelijken met 
normwaarden. 
 17
De oriëntatiepunten bevinden zich 
op een beperkt gebied van de RSP; 
de gebieden boven de schedelbasis 
en onder de onderkaak zijn feitelijk 
onnodig, maar staan wel op de 
opname. Onder de onderkaak ligt 
bovendien de schildklier, die meer 
dan andere weefsels gevoelig is 
voor de nadelige effecten van 
röntgenstraling. 
Omdat röntgenstraling potentieel 
schadelijk is, is het bestralen van 
gebieden waar geen diagnostische 
informatie is te vinden onwenselijk 
en zelfs strijdig met de richtlijnen. De 
richtlijnen stellen dat de schildklier 
zich niet in de beeldvormende straling 
zou mogen bevinden. 
Meerdere onderzoekers hebben 
uitgezocht of het gebied boven de 
schedelbasis en onder de onderkaak 
af te schermen is met een masker 
dat de bundel begrenst. Dat zou de 
stralingsdosis voor patiënten met 
meer dan de helft terugbrengen. 
De aangedragen oplossingen zijn 
echter nooit in praktijk gebracht. 
Enerzijds komt dat omdat de 
RSP tegenwoordig met een 
combinatieapparaat wordt gemaakt 
waarop een dergelijk masker niet 
te plaatsen is, anderzijds omdat de 
onderkaak bij verschillende patiënten 
niet altijd op dezelfde plaats op de 
RSP staat. Afscherming van altijd 
hetzelfde gebied zou er soms toe 
leiden dat informatie verloren gaat, 
terwijl bij andere patiënten de 
schildklier evengoed nog binnen de 
bundel valt. 
Op basis van deze gegevens ontstond 
het idee het gebied boven de 
schedelbasis en het gebied onder 
de onderkaak met verschillende 
hulpmiddelen af te schermen, 
waarbij boven de schedelbasis op  
elke RSP hetzelfde gebied wordt 
afgeschermd en waarbij het gebied 
onder de onderkaak voor elk individu 
de afscherming wordt bepaald.  
Hoofdstuk 2 beschrijft het ontwerp 
van een schild (ACC) dat het gebied 
boven de schedelbasis afschermt. 
Hoofdstuk 3 beschrijft het onderzoek 
om uit te zoeken of wanneer door 
dit hulpmiddel een vast gebied op 
alle RSP’s wordt afgeschermd de 
diagnostische waarde intact blijft. 
Het gebied van de schildklier kan 
worden afgeschermd met een 
loodkraag. In de praktijk wordt deze 
weinig gebruikt. Er zijn aanwijzingen 
dat een oorzaak hiervoor is dat 
orthodontisten de nekwervels op een 
RSP willen kunnen zien. Op basis van 
de vorm van de nekwervels schatten 
zij in hoeveel de orthodontiepatiënt 
nog groeit. Dat leidde tot het idee 
een speciale schildklierbeschermer te 
ontwikkelen die de schildklier uit de 
bundel houdt zonder de nekwervels 
aan het zicht te onttrekken. 
Hoofdstuk 4 licht het design van 
deze schildklierprotector (CTP) toe 
en beschrijft een onderzoek naar 
de dosisreductie voor de patiënt 
als ACC en CTP ingezet worden. 
Voor dit onderzoek werden RSP’s 
gemaakt van een fantoomkop met 
dosismeters, zowel met als zonder 
beschermingsmiddelen. 
Tijdens dit onderzoek bleek dat 
veel van dit soort dosisonderzoeken 
wordt gedaan zonder de toevallige 
meetfout correct te rapporteren. 
Daardoor blijft onduidelijk of 
verschillen tussen opnamen met en 
zonder afscherming échte verschillen 
zijn, of verschillen die aan het toeval 
moeten worden toegeschreven. 
In hoofdstuk 5 onderzoeken we of 
simulatiesoftware het mogelijk maakt 
de meetfout correct te rapporteren.  
Het beperken van de stralingsdosis 
van de RSP door ACC en CTP lijkt 
positief, maar daar is tegenin te 
brengen dat de dosis bij een RSP 
al laag is en dat het mogelijk niet 
kosteneffectief zou kunnen zijn 
financiële middelen te besteden 
aan verdere reductie. In hoofdstuk 
6 wordt onderzocht of er een 
gefundeerde kosten-batenanalyse te 
maken is die én consistent is én aan 
te passen aan het risicoprofiel voor 
nadelige effecten van röntgenstraling 
van specifieke patiëntengroepen. 
In hoofdstuk 7 tenslotte staat de 
discussie over de bevindingen uit de 
verschillende hoofdstukken en de 
conclusies.
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Anatomically shaped cranial 
collimation (ACC) for lateral 
cephalometric radiography
This chapter was published as:
R.C. Hoogeveen, P.F. van der Stelt and W.E.R. Berkhout
Anatomically shaped cranial collimation (ACC) for lateral 
cephalometric radiography: a technical report.
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It has occurred to many in our profession that a lateral 
cephalogram, an X-ray exposure that is frequently used in 
orthodontics, displays a larger area of the skull than is required 
for diagnostic evaluation. X-rays are potentially harmful, 
especially for younger patients, who make up most of the 
population undergoing orthodontic treatment.1 In line with 
the recommendations of the International Commission on 
Radiation Protection and other national and international 
guidelines, clinicians are advised to restrict the area of interest 
to ensure maximal radiological hygiene.2,3,4 Early orthodontic 
cephalography depicted the complete skull. Modern 
cephalometric machines use rectangular collimation of the beam 
to limit exposure to the regions that have diagnostic value. 
Even with appropriate rectangular collimation, there are still considerable 
areas on the image where no diagnostic orthodontic information is found. 
These regions are located above and behind the base of the skull and the 
petrous part of the temporal bone, and below the mandible.5 Additional 
collimation was described by L’Abée and Tan6 in 1982 and a joint working 
party of the British societies of orthodontists and maxillofacial radiologists in 
1985.7 They proposed that wedge-shaped collimators could be used to shield 
the area above the base of the skull and below the mandible, that only left 
visible an area restricted to the maxilla and mandible. These collimators were 
designed to be placed approximately halfway between the X-ray source and 
the cephalostat as part of a dedicated cephalometric installation. In 1999, 
Mandall et al8 investigated the diagnostic value of conventional cephalograms 
that were modified to appear as if they were produced using wedgeshaped 
collimation. They found that cephalometric imaging using modified collimation 
was feasible for patients wearing orthodontic fixed appliances. In 2003, 
Gijbels et al9 also advocated the use of a wedge-shaped collimator mounted 
on the X-ray tube. It achieved more than 40% dose reduction when tested on 
a phantom head with inserted dosemeters (Figure 1). In 2009, Alcaraz et al10 
designed and tested a prototype of a wedge-shaped collimator that could be 
mounted on a specific combination panoramic–cephalometric imaging system. 
Figure 1 – 
Wedge-shaped collimator (left) and 
schematic representation of the position 
of the collimator on the cephalogram. 
Reproduced with permission from the 
British Institute of Radiology, from Gijbels 
et al9
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They found up to 60% dose reductions but concluded that the area below the 
mandible was not effectively shielded without individual modification of the 
collimator for each patient. In 2012, Lee et al11 modified the wedge-shaped 
collimator used by Gijbels et al and evaluated the dose using Monte Carlo 
simulation. They also found approximately 60% dose reduction.
Drawbacks of proposed collimators
Although high percentages of dose reduction were reported, these collimators 
are still not commonly used in orthodontic practice.12 There are three 
possible reasons for this. One explanation is that today’s orthodontic offices 
use combination panoramic–cephalometric imaging systems. Mounting a 
collimator on the X-ray tube or halfway between the X-ray tube and the 
patient is not practical with these machines. Another problem with these 
modified designs is that individual mandibles vary substantially in size, shape 
and location when projected on the cephalogram. Investigators using phantom 
heads to test collimators did not take into account this anatomical variability, 
which requires individual adjustment of the shielding. Without adjustment, 
there will either be too much shielding in patients with mandibles that grow 
or are located lower than average or not enough shielding for patients who 
have smaller or more superiorly located mandibles.10 Finally, a wedgeshaped 
collimator may block imaging of the cervical vertebrae. Depiction of the 
cervical vertebrae has become desirable since the developmental stages of 
these vertebrae have been used as indices of skeletal maturation.13 In contrast 
to the mandible, there is less variation in the size and shape of the base of 
the skull because the chondrocranium follows a well-defined developmental 
path. In addition, growth of the base of the skull is almost complete by the 
time cephalograms are made for orthodontic purposes.14 The position of 
the base of the skull on the cephalogram is dictated by its close association 
with the external auditory canals, which are used to stabilize the head of 
the patient during cephalography. Although there is still considerable bone 
growth around the meatus after the age that orthodontic diagnostics are first 
performed, this growth is in the direction of the X-ray beam and therefore 
does not displace the image of the base of the skull on the cephalogram as 
the patient matures. Therefore, wedge collimation may reduce the patient’s 
radiation dose, although the technique has not found acceptance in clinical 
orthodontics. If and when the lower half of the collimation could be eliminated 
and the collimator redesigned for the combination panoramic–cephalometric 
imaging systems, it could find its way into orthodontic offices leading to 
reduced radiation dose from cephalography. 
A suitable collimator for combination imaging systems would be attached to 
the ear post of the cephalostat that is closest to the X-ray source. A wedge-
shaped collimator with this type of mounting was described by Cipollina and 
Jerrold15 in a 1984 US patent. The border of a wedge-shaped collimated beam 
relative to the base of the skull is, in general, an arbitrarily chosen oblique 
line that parallels the base of the skull. Because the projection of the base of 
the skull is stable, it should be possible to design a collimator with a lower 
edge that approximates the base of the skull more closely. A ‘onesize-fits-all’ 
collimator that can be permanently attached to the ear post and does not 
require adjustments or disassembly would facilitate the implementation of 
wedge collimation.
The aim of this study was to evaluate whether a collimator for the cranial 
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area of the skull could be constructed and attached to the cephalostat that 
would markedly reduce the area of irradiation while preserving the view of 
diagnostically relevant structures. To undertake this study, the shape of the 
area to be shielded was determined from the cephalographic anatomy of 
orthodontic patients. To determine whether this shape led to substantial 
reduction of the irradiated area of the patient, areas were measured. A 
collimator, referred to in this article as an anatomically shaped cranial 
collimator (ACC), was constructed that shielded this area. This collimator was 
tested to determine if it shielded the intended area and the following were 
secondary questions. 
1 Does the ACC affect the exposure settings of the machine? 
2  Does the ACC lead to reduced quality of the cephalogram or interfere with 
other exposure modalities of the machine? 
3 Is it possible to use the ACC with different imaging systems?
We did not study the shielding of the area under the mandible because of 
its variable anatomy and position in relation to the cephalostat. This area 
should be shielded using another method, such as a thyroid collar, which is not 
addressed in this study. 
MATERIALS AND METHODS
Determining the shape of the area to be shielded The cranial landmarks used 
the most in current conventional cephalometric analysis are located at or 
below the base of the skull and the petrous part of the temporal bone. Ideally, 
the border of the shielded area is located immediately superior to these 
structures. From posterior to anterior, the border of the area to be shielded 
follows the inner contour of the posterior cranial vault, progresses over the 
Figure 2 – 
Border of the area to be shielded. 
Schematic representation of the ‘border 
landmarks’; Points 1 to 8: 
1 – frontal bone at edge of beam; 
2 –  most anterior inner contour of frontal 
bone; 
3 – roof of orbit; 
4 – pterygoid–sphenoid intersection; 
5 – anterior clinoid; 
6 – posterior clinoid; 
7 –  ridge of the petrous part of the 
temporal bone; 
8 –  most inferior inner curvature of 
occipital contour. 
The points are represented by a cross 
inside an oval; the dimensions of the oval 
represent the size of 1 standard deviation 
(SD) (horizontal direction for x-coordinate 
and vertical direction for y-coordinate), 
except for Points 5 and 6, where they 
represent 2 SDs.
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petrous part of the temporal bone, follows the clivus over the sella turcica 
and, finally, proceeds along the roof of the orbits into the internal contour of 
the frontal bone (Figure 2).
To determine the location of this boundary on cephalograms, we chose eight 
‘border landmarks’ to evaluate (Figure 2). One hundred cephalograms from 
consecutive patients undergoing orthodontic treatment planning at the 
office of one of the authors were used. The mean age of these patients (60 
females and 40 males) was 13.0 years [standard deviation (SD), 6.6 years]. 
The study patients were 95% Caucasian, 3% Asian and 2% North African. 
The cephalograms were made using a Morita Veraviewepocs® 3D X550 X-ray 
unit (J. Morita Company, Kyoto, Japan) equipped with a charge-coupled 
device sensor and operated at 90 kV and a tube current with a programmed 
shift [maximum of 10 mA, the density compensation (DC) setting], with an 
exposure time of 4.9 s per exposure. The border landmarks were identified, 
and their coordinates were recorded using Viewbox software v.3 (dHAL 
Software, Kifissia, Greece). 
The mean x- and y-coordinates and SD were determined for each border 
landmark using Microsoft Excel® 2003 software (Microsoft Corporation, 
Seattle, WA). The mean coordinates of the border landmarks were plotted 
on a graph using SolidWorks® 3D Computer-Aided Design (CAD) software 
v. 2011 (Dassault Systèmes SolidWorks®, Waltham, MA). A line was drawn 
that followed the co-ordinates, which represented the mean inferior border 
of the area that was to be shielded. A collimator that casts its shadow along 
this line would result in too much shielding in half the patients. This would 
lead to loss of diagnostic information. Use of the SDs of the measurements 
to determine the required distance from the mean line allowed us to adjust 
the shape of the shielded area to reduce the risk of too much shielding.
Structures with diagnostic importance near the border include the soft-tissue 
contour of the forehead and the following landmarks called Nasion, Sella, 
Porion and Basion. Sella and the forehead are closest to the border. 
If the collimator shields Sella so that it does not appear on the cephalogram, 
the image would be seriously compromised because Sella is frequently 
used in cephalometric analysis. The sella turcica, where landmark Sella is 
located, is a recognizable and stable feature on the base of the skull and is 
important for superimposing different cephalograms of the same patient to 
assess growth or treatment. If the contour of the forehead is not completely 
visible on a cephalogram, it is usually not necessary to perform additional 
cephalography. Therefore, to avoid the risk of having to retake images, 
a larger margin was determined for Sella than for the forehead when the 
shape and size of the shielded area was established.
The SDs of the x- and y-coordinates of the border landmarks were used to 
depict a graphic representation of the variability, which were drawn around 
the mean coordinates of the landmarks as ovals. The vertical radius was 
the SD of the y-coordinate and the horizontal radius was the SD of the 
x-coordinate. To assure that the risk of shielding Sella was very small, an oval 
of two SDs was drawn around the border landmarks (anterior and posterior 
clinoid) near Sella. The inferior border of the area to be shielded was drawn 
along the superior edge of these ovals (Figure 2).
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Measuring the reduction of irradiated area 
To assess the reduction of the irradiated areas of the patients, areas were 
measured on the 100 cephalograms using SolidWorks CAD software. 
The coinciding area of the images of each patient’s head and the shadow 
produced by the ACC were measured, and the percent reduction was 
determined using the total area of the patient’s head on the images. The mean 
reduction, SD, and range were calculated using Microsoft Excel 2003 software.
Construction of the anatomically shaped cranial collimator
A collimator was constructed to cast a shadow in the shape of the area to be 
shielded when mounted on the ear post of the cephalostat between the X-ray 
source and the patient. SolidWorks CAD software was used to make a model 
of the cephalometric components of the Morita Veraviewepocs 3D X-ray unit. 
The shape, position and dimensions of ACC to shield the intended area were 
modelled using a source-to-image distance of 1650 mm, source-to-object 
(mid-sagittal plane) distance of 1500 mm, magnification factor (MF) of 1.1 
for the mid-sagittal plane and geometry with the central beam through the 
middle of the ear plugs (Figure 3).
The shape and dimensions were programmed into a high-pressure water-
cutting machine (ByJet 4022, Waterjet Cutting System; Bystronic, Niederönz, 
Switzerland) that cut a 1mm sheet of lead. 1mm lead was chosen because it 
attenuates 99% of the X-ray photons at 90 kV.16 The lead sheet was reinforced 
with a 2mm piece of polyvinyl chloride of the same size and shape, which 
was glued to the sheet. A bracket was fixed to the ACC with two bolts. This 
bracket was fitted with a rubber lining to precisely match the form of the ear 
post of the cephalostat.
The ACC prototype was then fixed to the ear post that was nearest to the 
X-ray source at the position relative to the middle of the earplug, which 
was determined by the computer model (Figure 4). Exposures without 
patients were made to determine whether the position of the X-ray shadow 
corresponded with the area targeted for shielding. SolidWorks CAD software 
was used to verify that the actual shielding closely corresponded to the target 
area by measuring the difference in millimetres between the inferior borders.
Figure 3 – 
Geometry of the projection of the 
collimator illustration made with the 
modelling software showing the geometry 
of the diverging X-ray beam, resulting in 
enlargement of the shadow cast by the 
collimator on the image recording plane. 
The X-ray source is the viewpoint of the 
image on the left. The X-ray source is to 
the right of the image that is on the right 
at the converging point of the three lines 
representing the divergence of the X-ray 
beam.
 25
Anatomically shaped cranial collimator 
interference with image formation 
X-ray machines with direct digital sensors, such as the unit used in this 
research, can modulate their output in relation to the levels of radiation 
detected by the sensor. When there is a large radio-opaque object in the path 
of the beam, this automatic exposure control may result in increased output by 
the generator, which would nullify the effect of the ACC. The Morita machine 
does not use automatic exposure control in the cephalometric mode but has 
a DC function. DC results in a programmed shift of the tube current during 
the exposure to  improve depiction of the soft tissues. To determine that DC 
would not increase the tube current when the ACC was used, four exposures 
of a phantom head were made as follows: with and without ACC and with 
and without DC. During these exposures, dose area product values were 
determined near the generator using an ionization chamber (VacuDAP 2000; 
VacuTec GmbH, Dresden, Germany).
Figure 4 – 
Patient in cephalostat with anatomically 
shaped cranial collimator (ACC) attached. 
Patient positioned in the cephalostat of 
the Morita Veraviewepocs® 3D X550 X-ray 
unit (J. Morita Company, Kyoto, Japan) 
with ACC mounted on the ear rod closest 
to the X-ray source.
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Images of the phantom head were also used to determine whether the ACC 
affected the quality of the images. Image subtraction using Emago® v.6 
software (Oral Diagnostic Systems, Amsterdam, Netherlands) was performed 
on the images produced with and without ACC. 
To use a combination cephalometric–panoramic imaging system to make 
posteroanterior cephalograms and hand–wrist exposures, the cephalostat 
is turned 90°, which moves the ear post with the ACC to the periphery of 
the field. To determine whether the ACC interfered with these exposure 
modalities, the positioning of a patient for posteroanterior exposure and 
hand–wrist exposure was simulated, and posteroanterior exposures were 
made of a phantom head.
To assess the projection of the ACC when used in combination with other 
cephalometric machines, computer models were developed with MFs varying 
between 1.10 and 1.15. This range corresponds to the variation of common 
X-ray machines with source-to-image distances ranging from 1650 mm to 
1150 mm. The difference in projection of the lower border of the ACC on the 
image plane relative to the different projections of the mid-sagittal plane was 
assessed in millimetres.
RESULTS
Shielded area
To determine whether the ACC shielded the intended area, images of 
exposures made with the presence of ACC were evaluated. SolidWorks CAD 
software found that the difference between the actual and intended shielding 
was less than or equal to 1.75 mm.
Figure 5 – 
Cephalogram made with Anatomically-
shaped Cranial Collimator.
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Measurements of the area of shielding and the projection of the head of the 
patient were performed on the 100 cephalograms used to design the ACC. 
On every cephalogram, the area of intended shielding that coincided with 
the projection of the head of the patient was assessed using SolidWorks CAD 
software. The area that coincided was expressed as a percentage of  the total 
area of the image of the patient. On average, it appeared that the reduction 
in the irradiated area was 31.2% (SD, 1.94%; range, 27.2–35.5 %) of the 
irradiated area of the patient (Figure 5).
Effects on image
The ACC did not change the output of the generator. Dose area product 
values measured in front of the generator were not affected, whether or not 
the ACC was used during exposures of a phantom head.
Subtraction of the images made with and without the ACC showed that the 
mean grey values of the image were unchanged, except for the area shielded 
when the ACC was used (Figure 6).
The ACC was not found to interfere with posteroanterior exposures. The 
ear post with the ACC was projected as a thin radio-opaque structure at the 
border of the image and did not interfere with the projection of the head of 
the patient. Hand–wrist exposures were made with the cephalostat in the 
same position and the ear posts positioned as wide as possible. The exposure 
made with the ear posts in this position did not show the ear posts or the ACC 
on the image. 
Calculations showed that the differences in collimation by an optimized ACC 
caused by differences in MF were very limited. The differences at the central 
Figure 6 – 
Subtraction image of an image with and 
without the presence of anatomically 
shaped cranial collimator (ACC). Image as 
a result of the subtraction performed by 
Emago® v.6 software (Oral Diagnostic
Systems, Amsterdam, Netherlands) of the 
cephalograms of a phantom head made 
with and without the presence of ACC. 
Unchanged areas of the image had a mean 
value of 128 (total scale is 256 Gy values).
The mean value of the large rectangular 
area below the collimator (1) was 125.2 
(SD, 7.0), and the value of the rectangular 
area in the shielded area (2) was 217.7 
(SD, 7.9).
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area of the base of the skull were less than or equal to 1.2mm. The differences 
at the periphery of the image, which is further from the central beam, were 
less than or equal to 2mm.
DISCUSSION
This report described the design of a collimator for cephalometry. The 
purpose of its design was to reduce the radiation dose of the patient and to 
be easily implemented in orthodontic practice. Therefore, it was designed to 
be used in combination panoramic–cephalometric imaging systems without 
needing to adjust or disassemble it for individual exposures. The ACC reduced 
the irradiated area of the patient by almost one-third. The location of the ACC 
on the ear post of the Morita equipment did not affect the imaging process 
adversely. In addition, the ACC did not interfere with the other imaging 
modalities performed by the machine.
A required clinical follow-up study, which is now being carried out in 
our department, will determine whether the landmarks that are used in 
orthodontic cephalometry will remain exposed when the ACC is used. 
The ACC was based on the analysis of the morphology of the cranial base of 
100 consecutive Dutch orthodontic patients, 95% of whom were Caucasian. 
Therefore, the clinical performance of the collimator must also be evaluated 
in populations with different ethnicities. It is conceivable that a collimator with 
different dimensions will be needed for different ethnicities. 
It is important to determine whether the design will be usable on different 
X-ray machines. In this study, computer modelling established that the 
different MFs that are used in the currently available machines would have 
minimal effect on exposures produced using the ACC. The change in the 
projection of the ACC relative to the change in position of the image of the 
patient is around 20% of the SD of the variation in the anatomy of the study 
patients. Therefore, different machines can use the same ACC. However, the 
mounting on the ear post will require a variety of brackets to accommodate 
the different types of X-ray machines. 
This ACC produced a smaller dose reduction than previously reported for 
wedge-shaped collimators. The irradiated area was reduced by 27–35%. The 
actual amount of reduction of the (effective) dose will be determined in a 
follow-up study. Because millions of cephalograms are taken worldwide each 
year and a relatively large proportion of orthodontic patients are young, the 
potential reduction in radiation risk is meaningful. 
The Morita X-ray unit used in the development of our collimator did not 
generate an increased X-ray output in response to the radiopaque shield 
that was in the path of the X-ray beam, but other machines may increase 
their radiation output. The use of our collimator will only be viable for these 
machines if the automatic exposure control function is disabled. There is no 
problem for machines that use photostimulable phosphor plates because 
there is no direct feedback by a sensor that would affect the output of the 
X-ray generator. To improve the quality of cephalograms, image enhancement 
software is integrated into cephalometric systems. This ACC shields a large 
area from radiation, and the image produced using this ACC has a large 
shadow. It is possible that certain software may react adversely to a large 
amount of pixels with low grey values. This did not occur with the Morita 
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system used to develop the ACC. Investigations must be performed to 
determine if the image enhancement software of other systems is perturbed 
by ACC. The settings of affected software would require adjustments to use 
this collimator. 
In conclusion, this report described a collimator design that reduced the 
irradiated area of the patient by almost one-third while leaving diagnostically 
relevant structures exposed and not adversely affecting the function of the 
X-ray system. The shortcomings of earlier attempts to achieve these goals 
were eliminated by the current design, which focused on the area cranially 
at the base of the skull. The inferior border was located at a well-defined 
distance from and approximated the average anatomical shape of the base of 
the skull. In addition, the collimator was modified for use with a combination 
panoramic–cephalometric imaging machines.  Further validation studies 
and research and development are needed before ACC is incorporated into 
orthodontic practice.
A ‘onesize-fits-all’ collimator that can be 
permanently attached to the ear post 
and does not require adjustments would 
facilitate implementation
30    –    CHAPTER 2
REFERENCES
1  ICRP. 1990 Recommendations of the International Commission on Radiological Protection. 
 Ann ICRP 1991; 21: 1–41
2  European Commission. Radiation protection 136, European guidelines on radiation protection in 
dental radiology: the safe use of radiographs in dental practice. Luxembourg: Office for Official 
Publications of the European Communities; 2004. Available from: ec.europa.eu/energy/nuclear/
radioprotection/publication/doc/136_en.pdf
3  Horner K. Review article: radiation protection in dental radiology. Br J Radiol 1994; 
 67: 1041–1049
4  ICRP. The 2007 Recommendations of the International Commission on Radiological Protection. 
ICRP publication 103. Ann ICRP 2007; 37: 1–332
5  Bosch C, Athanasiou AE. Landmarks, variables and norms of various numerical cephalometric 
analyses–cephalometric morphologic and growth data references. In: Athanasiou AE, ed. 
Orthodontic cephalometry. London: Mosby-Wolfe; 1995. pp. 241–285
6  L’Abée EM, Tan HT. Improved radiation hygiene in lateral cephalometry and a method to obtain 
good reproduction of the soft tissue profile. J Clin Orthod 1982; 16: 381–386.
7  Hirschman PN, Lovelock DJ, Gravely JF, Senior WB. The reduction of the dose to patients during 
lateral cephalometric radiography.
 Report of a Joint Working Party of the British Society for the Study of Orthodontics and the  
 British Society of Dental and Maxillofacial Radiology. Br J Orthod 1985; 12: 176–178.
8  Mandall NA, O’Brien KD, Worthington HV. Radiation reduction using a modified collimated 
lateral skull radiograph during orthodontic treatment. Clin Orthod Res 1999; 2: 179–185
9  Gijbels F, Sanderink G, Wyatt J, Van Dam J, Nowak B, Jacobs R. Radiation doses of collimated 
 vs non-collimated cephalometric exposures. Dentomaxillofac Radiol 2003; 32: 128–133
10 Alcaraz M, García-Vera MC, Bravo LA, Mart´ınez-Beneyto Y, Armero D, Morant JJ, et al.  
  Collimator with filtration compensator: clinical adaptation to meet European Union 
recommendation 4F on radiological protection for dental radiography. Dentomaxillofac Radiol 
2009; 38: 413–420
11  Lee B, Shin G, Kang S, Shin B, Back I, Park H, et al. Dose evaluation of selective collimation 
effect in cephalography by measurement and Monte Carlo simulation. Radiat Prot Dosimetry 
2012; 148: 58–64. doi: 10.1093/rpd/ncq596
12  Hujoel P, Hollender L, Bollen AM, Young JD, Cunha-Cruz J, McGee M, et al. Thyroid shields and 
neck exposures in cephalometric radiography. BMC Med Imaging. 2006;6:6. 
 doi: 10.1186/1471-2342-6-6
13  Baccetti T, Franchi L, McNamara JA, Jr. The cervical vertebral maturation (CVM) method for the 
assessment of optimal treatment timing in dentofacial orthopedics. Semin Orthod 2005; 
 11: 119–129
14 Enlow DH, Hans MG. Essentials of facial growth. Philadelphia, PA: Saunders; 1996.
15  Cipollina JJ, Jerrold LE, inventors. Cephalometric shield. United States Patent US 4490616. 
 1984 Dec 25
16  Archer BR, Fewell TR, Conway BJ, Quinn PW. Attenuation properties of diagnostic x-ray 
shielding materials. Med Phys 1994; 21: 1499–1507
 31
ABSTRACT 
CHAPTER 2
Lateral cephalograms in orthodontic 
practice display an area cranial of the 
base of the skull that is not required 
for diagnostic evaluation. Attempts 
have been made to reduce the 
radiation dose to the patient using 
collimators combining the shielding 
of the areas above the base of the 
skull and below the mandible. These 
so-called ‘wedge-shaped’ collimators 
have not become standard equipment 
in orthodontic offices, possibly 
because these collimators were not 
designed for today’s combination 
panoramic–cephalometric imaging 
systems. It also may be that the 
anatomical variability of the area 
below the mandible makes this 
area unsuitable for standardized 
collimation. In addition, a wedge-
shaped collimator shields the cervical 
vertebrae; therefore, assessment 
of skeletal maturation, which is 
based on the stage of development 
of the cervical vertebrae, cannot 
be performed. In this report, we 
describe our investigations into 
constructing a collimator to be 
attached to the cephalostat and 
shield the cranial area of the skull, 
while allowing the visualization of 
diagnostically relevant structures 
and markedly reducing the size of 
the irradiated area. The shape of the 
area shielded by this ‘anatomically 
shaped cranial collimator’ (ACC) 
was based on mean measurements 
of cephalometric landmarks of 100 
orthodontic patients. It appeared that 
this collimator reduced the area of 
irradiation by almost one-third without 
interfering with the imaging system or 
affecting the quality of the image. 
Further research is needed 
to validate the clinical efficacy 
of the collimator.
NEDERLANDSE SAMENVATTING 
HOOFDSTUK 2
Röntgenschedelprofielopnamen 
voor orthodontische behandelingen, 
beelden ook altijd een gebied af 
boven de schedelbasis dat niet nodig 
is voor de diagnostiek. In het verleden 
zijn er pogingen gedaan om de dosis 
voor de patiënt te verlagen door de 
gebieden boven de schedelbasis en 
onder de onderkaak af te schermen. 
Deze afscherming, die wigvormige 
collimatie werd genoemd, is 
niet in gebruik gekomen in 
de orthodontische praktijk. 
Hiervoor zijn drie redenen te 
bedenken. De eerste is dat deze 
afscherming niet past bij de huidige 
generatie röntgentoestellen in de 
orthodontiepraktijk. Een andere reden 
is dat standaard afscherming botst 
met de variabiliteit van de positie 
van de onderrand van de onderkaak. 
Ten derde komen bij gebruik van 
de wigvormige collimator de de 
nekwervels niet in beeld waarmee de 
skeletale rijping op basis van de vorm 
van de nekwervels te beoordelen is. 
Dit hoofdstuk beschrijft een 
collimator voor het gebied boven 
de schedelbasis die diagnostisch 
relevante anatomische structuren 
zichtbaar laat, terwijl een aanzienlijk 
kleiner gebied bestraald wordt. De 
vorm van deze Anatomische Craniale 
Collimator (ACC) is gebaseerd op 
de gemiddelden van anatomische 
oriëntatiepunten bij 100 individuen. 
Deze ACC vermindert het bestraalde 
gebied met bijna een derde zonder 
het beeldvormende systeem te storen 
of de beeldkwaliteit te beïnvloeden. 
Verder onderzoek is nodig om de 
klinische werkzaamheid van de ACC 
te valideren. 
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Validation of anatomically shaped cranial 
collimation (ACC) in orthodontic lateral 
cephalography 
This chapter was published as:
R.C. Hoogeveen, P.J. Guicherit, S.R. Gopie, P.F. van der Stelt and 
W.E.R. Berkhout
Validation of anatomically shaped cranial collimation (ACC) in orthodontic 
lateral cephalography.
In Dentomaxillofacial Radiology 2014; 43: 20130396
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Cephalograms are commonly used for orthodontic diagnosis 
and treatment planning. Orthodontists perform cephalometric 
analyses on these images by identifying landmarks and 
structures and measuring distances and angles. In commonly 
used cephalometric protocols, the landmarks and structures 
identified are limited to an area antero-inferior to the skull base. 
On these cephalograms, an area without diagnostic information 
is defined to be postero-superior to the skull base. Owing to 
the potential detrimental effects of ionizing radiation, clinicians 
are obliged to shield areas of no interest when ‘reasonably 
achievable’ as defined by the as low as reasonably achievable 
(ALARA) principle stated in international guidelines.1,2 
The literature contains descriptions of a number of collimators that have been 
developed to comply with these guidelines.3–7 Unfortunately, these collimators 
have not achieved wide acceptance in the orthodontic field.8 This could be 
because the proposed collimators were designed for dedicated cephalometric 
X-ray installations but not for the currently used combined panoramic–
cephalometric machines. Another reason could be that the collimators that 
were proposed shield the aforementioned cranial area together with the 
area of the thyroid gland below the mandible. Clinicians might be rejecting 
these collimators because of the significant likelihood of a loss of diagnostic 
information when the mandible is partly obstructed by over-collimation as a 
result of the anatomical variability of the mandible. 
To overcome these problems and search for broad clinical acceptance an 
anatomically shaped cranial collimator (ACC) was designed and presented in 
a technical report by the authors of this article.9 This design was based on the 
average anatomy of a group of Dutch orthodontic patients and the geometry 
of a panoramic–cephalometric X-ray unit. It was designed to be mounted on 
the ear rod of the cephalostat. The ACC reduces the irradiated area of the 
patient by 31.2% [standard deviation (SD), 1.94%; range, 27.2–35.5%).9 Similar 
to the use of rectangular collimation in intraoral radiography, the reduction of 
patient dose comes with a disadvantage. 
In the case of rectangular collimation, this disadvantage is the occurrence of 
cone cutting, which is acceptable because it is outweighed by the benefits of 
the reduction of field size. With the use of the ACC, the disadvantage could 
be the interference with landmark identification owing to the collimation of 
relevant structures. To assess the overall performance of ACC, it is necessary 
to determine the frequency of this interference. The thyroid area is not 
shielded with this device; however, clinicians can use alternative measures 
to shield this area. The aim of this study was to evaluate the extent of 
interference by the use of the ACC on the diagnostic process of landmark 
identification on cephalograms made for orthodontic purposes. 
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METHODS AND MATERIALS
To investigate the possibility of obstruction of diagnostically relevant 
anatomical landmarks by the ACC, fi ve structures in the vicinity of the border 
of the ACC were chosen. These landmarks were the basion, porion, sella, 
nasion and the soft-tissue contour of the forehead (Figure 1). From their 
position on the cephalogram and the form of the ACC, it can be deduced 
that, if identifi cation of these structures is not hindered, no other relevant 
anatomical structures will be obscured by the presence of the ACC. Of these 
fi ve structures, it can be assumed that they are always visible on cephalograms 
made without the ACC. This led to a research design where observers 
were shown cephalograms made with the ACC to assess the interference 
in landmark identifi cation of the fi ve structures. It was assumed that, when 
an observer stated that identifi cation of the landmark was unhindered, the 
cephalometric measurements based on the use of this structure would have 
the same accuracy as if the cephalogram was taken without the ACC present. 
An alternative study design in which two cephalograms of the same patient, 
one with and one without the ACC, could be compared by cephalometric 
analysis was considered. It was rejected because of the additional X-ray 
Figure 1 –  
Cephalogram made with the use of the 
anatomically shaped cranial collimator (A) 
and thyroid shielding with a thyroid collar 
(B). Cephalometric landmarks involved in 
this study: basion (1), porion (2), sella (3) 
and nasion (4).
Table 1 – 
Characteristics of patients who underwent 
cephalograms. 
SD = standard deviation
95% of the patients were white
gender frequency age (mean) (SD)
male 44 12.1 3.5 
female 56 12.4 4.9 
total 100 12.3 4.4
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dose to the patient and the anticipated small effect of the collimation on the 
cephalometric values, thus requiring a large number of double cephalograms 
to obtain adequate power to draw statistically significant conclusions. 
A total of 100 consecutive cephalograms that were recorded with the use of 
the ACC and conducted in the context of orthodontic treatment planning 
were retrieved from the records held at the office of the first author. If a 
cephalogram had to be retaken during this series, the first image was included 
in this survey, and the second image was excluded. The characteristics of 
the patients involved are presented in Table 1. All patients provided written 
consent for the use of their records for research purposes. The exposures were 
made with a Veraviewepocs® 3D X550 (J. Morita Co., Kyoto, Japan) equipped 
with a charge-coupled device sensor, following the manufacturer’s settings, 
operated at 90 kV and a tube current with a programmed shift (maximum of 
10 mA ‘density compensation’ setting) and a 4.9 s/exposure.
Ten observers viewed the cephalograms, which were displayed on a high-
resolution, 30-inch screen monitor (UltraSharp U3011 R; Dell Inc., Round Rock, 
TX). The observers comprised eight orthodontic residents, one orthodontist 
and one maxillofacial radiologist. The observers were not allowed to adjust the 
contrast or brightness of the images or to use zoom. They were asked to judge 
if the identification of five anatomical structures was unaffected, hindered or 
100  
cephalograms
made with 
ACC present
97  
cephalograms
no hindrance by
ACC reported
image #8
image #64
image #97
 number of observers who reported
LM no hindr hindr imposs
basion 9 1 0
porion 10 0 0
sella 2 8 0
nasion 10 0 0
ST forehead 10 0 0
basion 10 0 0
porion 10 0 0
sella 7 3 0
nasion 10 0 0
ST forehead 10 0 0
basion 10 0 0
porion 10 0 0
sella 10 0 0
nasion 10 0 0
ST forehead 8 2 0
Figure 2 – 
Schematic representation of the results of 
the observations. 
ACC: the anatomically shaped cranial 
collimator; 
Hindr: identification of landmark/structure 
is hindered by the presence of the ACC; 
Imposs: identification of landmark/structure 
is impossible owing to the presence of the
ACC; 
LM: landmark or structure; 
NoHindr: identification of landmark/
structure is unhindered by the presence of 
the ACC; 
ST: forehead, softtissue contour of the 
forehead.3
cephalograms
hindrance by
ACC reported
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made impossible as a result of the use of the ACC. These structures were the 
basion, porion, sella, nasion and the soft-tissue contour of the forehead. If the 
observers reported hindrance of the identification of any of these structures on 
a cephalogram, they were asked to state if they thought that a retake of this 
cephalogram would be necessary in clinical orthodontic practice.
STATISTICS
As this is an observational study that did not compare different modalities, 
the statistics were predominantly limited to descriptive statistics. The 
percentage of images without hindrance reported by all of the observers 
was calculated, as was the percentage of the 500 structures (5 structures on 
100 cephalograms) unanimously judged to be without hindrance. Also, the 
percentage of structures that were judged to be impossible to identify by one 
or more of the observers was calculated, the same requirements were used for 
the percentage of images that were considered to require a retake by one or 
more of the observers. 
To assess observer agreement, the percentage of unanimous rulings of the 500 
independent structures was calculated. All calculations were performed using 
Microsoft® Office Excel 2003 (Microsoft, Redmond, WA). 
RESULTS
The results of the observations are shown in Figure 2. In 97 of the 100 
images (97%), no hindrance was reported in identifying the 5 structures by 
any observer. Of the 500 structures that were judged, 496 structures (99.2%) 
were unanimously judged as unhindered by the ACC. In no instance (0%) did 
an observer rate a structure to be impossible to identify. Of the 5000 total 
judgments made, 14 noted hindrance. Sella was reported hindered by 8 of the 
10 observers on 1 image and by 3 of the 10 on another. Nasion and porion 
were never rated as hindered, basion was reported hindered once by 1 of 
the 10 observers; and the soft-tissue contour of the forehead was reported 
hindered by 2 of the 10 observers on 1 image. In two instances, 1 of the 10 
observers (different observers on different images) stated that they thought a 
retake of the image was necessary. The agreement of the observers was high 
as they decided unanimously in 99.2% of the judgments made. 
DISCUSSION
A total of 100 cephalograms were assessed by 10 observers. For only three 
images, hindrance by the presence of the ACC was reported. Only in 1 
case, a majority (8 of 10 observers) agreed on hindrance in identifying the 
landmark sella; for the other instances, a minority reported hindrance. In no 
Hindrance was extremely limited 
and did not significantly reduce 
diagnostic yield
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case did the observers make the judgement that identification of a structure 
was impossible. In general, it can be stated that hindrance was extremely 
limited and did not significantly reduce diagnostic yield. Only twice did 1 
of the 10 observers indicate that a retake of an image was necessary. The 
fact that the observers did not concurrently rate any landmark impossible to 
identify appears contradictory. Apparently, these two observers thought that 
the hindrance on that single image could result in inadequate cephalometric 
diagnostics. Overall, only 2 of the 1000 judgements on retakes noted that a 
retake was required; thus, the retake frequency was negligible. One observer 
noted that a retake was indicated because a landmark that was not required to 
be assessed in this study (spheno-ethmoidal intersection) was not identifiable. 
This landmark is not part of commonly used orthodontic cephalometry; 
therefore, it was not included in this study. If the landmark spheno-ethmoidal 
intersection, or other landmarks postero-superior to the skull base, are to 
be identified on cephalograms, the outline of the ACC could be adapted to 
this use, or it could be considered that the ACC should not be used in this 
situation. 
This study involved cephalograms of a Dutch orthodontic population, 95% of 
whom were white. Other ethnic populations might have a different anatomy 
of the skull base. Therefore, the use of the ACC for populations of a different 
ethnic origin remains to be evaluated. 
In this study, the cephalograms were made with the same cephalometric 
X-ray unit. In systems with a different geometry of the source–object and the 
source–image distance, the magnification factors of the projection of the 
ACC relative to the projection of the anatomy of the patient might be a few 
millimeters different. In the design of the ACC, the anatomical variability of 
the population was taken into account. This anatomical variability is of the 
order of five times greater than the differences found by a different geometry 
with different X-ray systems.9 Therefore, it is not expected that hindrance in 
landmark identification would be significantly different with a different X-ray 
system. 
The reduction of the irradiated area of the patient with the ACC is 
accomplished with minimal negative consequences. One could argue that the 
fact that the ACC does not cause significant hindrance means that it has been 
constructed too small. A larger design might lead to increased obstruction of 
diagnostically relevant areas; however, the balance between dose reduction 
and diagnostic yield might still be superior. Theoretically, this might be correct 
reasoning; however, in orthodontic practice, it might lead to interference of 
the diagnostic processes and discontinuation of the use the ACC. The ACC 
was designed to be readily integrated into the dental office without the need 
to disassemble or reposition it for individual patients; this feature should 
hopefully lead to higher acceptance. The fact that there is some diagnostic 
interference, but not enough to require retakes, is likely to signify that its 
dimensions are suitable for its intended purpose. 
The percentage of reduction of the irradiated area of the patient does not 
directly correspond to the same percentage of effective dose reduction. 
Follow-up studies will be conducted to determine the reduction of the 
effective dose. 
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In conclusion, the use of the ACC results in only minimal diagnostic 
interference, while substantially reducing the irradiated area of the patient. 
The need to retake images as a result of obstruction of important diagnostic 
landmarks is rare. Its use in different ethnic groups and the actual reduction of 
the effective dose need to be investigated in future research.
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ABSTRACT 
CHAPTER 3
The use of an anatomically shaped 
cranial collimator (ACC) to reduce 
patient dose in orthodontic lateral 
cephalography was investigated in 
this study. The aim was to evaluate
the potential interference of the 
ACC on landmark identification 
for orthodontic  cephalometry. 
Consecutive orthodontic patients 
underwent a total of 100 
cephalograms using an ACC mounted 
on a Veraviewepocs® 3D X550 
(J. Morita Co., Kyoto, Japan) X-ray
unit. 10 observers were asked whether 
the identification of 5 landmarks close 
to the collimated area was hindered 
or rendered impossible by the 
presence of the collimator. Of
the 500 landmarks that were judged 
by the 10 observers, 496 (99.2%) were 
reported to lack hindrance. In three 
landmarks, a minority of the observers 
reported hindrance. In 1 landmark, 
8 of the 10 observers reported 
hindrance by the collimator. In no 
instance did the observers state that 
the identification of landmarks was 
impossible as a result of the
collimation. Application of the ACC 
on the cephalostat of the X-ray unit is 
a viable way of reducing patient dose, 
as it only marginally interferes with the 
diagnostic yield of the exposure. The 
need to retake images when the ACC 
is applied was found to be extremely
low.
NEDERLANDSE SAMENVATTING 
HOOFDSTUK 3
Dit hoofdstuk beschrijft het 
onderzoek naar het gebruik van 
anatomisch gevormde craniale 
collimatie (ACC) om de röntgendosis 
voor de patiënt te beperken. Het 
doel was de potentiële interferentie 
van de ACC bij het identificeren 
van de oriëntatiepunten voor 
orthodontische cephalometrische 
analyse te evalueren. Van honderd 
orthodontische patiënten werd 
een röntgenschedelprofielopname 
gemaakt waarbij de ACC werd 
gemonteerd op een röntgenapparaat 
van de firma Morita (J. Morita 
Co. Kyotot, Japan) van het type 
Veraviewepocs® 3D X550. 
Tien waarnemers beantwoordden 
de vraag of het door de ACC 
lastiger of zelfs onmogelijk was 
vijf oriëntatiepunten dicht bij 
de grens van het gecollimeerde 
gebied te identificeren. Van de 
500 oriëntatiepunten die werden 
beoordeeld, merkten alle tien 
waarnemers op dat dit bij 496 punten 
(99.2%) ongehinderd ging. Bij drie 
oriëntatiepunten rapporteerde een 
minderheid van de waarnemers 
hinder. Voor één oriëntatiepunt 
rapporteerden acht van de tien 
hinder, maar geen enkele waarnemer 
vond dat de ACC beoordeling 
onmogelijk had gemaakt. 
De conclusie luidt dat door een ACC 
op het röntgenapparaat monteren, 
de stralingsdosis voor patiënten op 
een praktische manier te verlagen is, 
zonder de diagnostische opbrengst 
van de opnamen meer dan marginaal 
te beïnvloeden. De kans dat opnamen 
overgemaakt moeten worden blijkt 
bovendien extreem laag. 
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Dose reduction in orthodontic lateral 
cephalography: dosimetric evaluation of 
a novel cephalographic thyroid protector 
(CTP) and anatomical cranial collimator 
(ACC)
This chapter was published as:
R.C. Hoogeveen, D. Rottke, P.F. van der Stelt and W.E.R. Berkhout
Dose reduction in orthodontic lateral cephalography: dosimetric evaluation 
of a novel cephalographic thyroid protector (CTP) and anatomical cranial 
collimator (ACC).
In Dentomaxillofacial Radiology 2015; 44: 20140260
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Lateral cephalograms are radiographs that are frequently used 
to plan and evaluate orthodontic treatment. The use of X-rays 
is considered to be potentially harmful, so clinicians are obliged 
to use X-rays prudently to ensure that the dose for the patient is 
‘as low as reasonably achievable’.1 One possible way to reduce 
the dose for the patient is by minimizing the irradiated area 
of the patient to the region of interest for the diagnostic task. 
Recently, the anatomical cranial collimator (ACC) was introduced 
to shield the area cranial of the skull base from radiation.2 
This cranial area is without diagnostic information to the orthodontist. 
Another area that is in the field of view of lateral cephalograms without 
diagnostic information is the thyroid region. The thyroid gland is one of the 
most radiosensitive organs in the head and neck region. The thyroid region 
does not contain diagnostic information for dental or orthodontic treatment. 
Therefore, attention should be paid not to expose this area to radiation 
during cephalography as elevated risk of thyroid cancer following external 
radiation has been demonstrated.3,4,5 Depending on the size of the patient and 
the collimation of the beam, the thyroid is partially or completely irradiated 
during a Cephalographic exposure when no shielding measures are taken.6 
The European guidelines on the safe use of radiographs in dental practice 
read: ‘in cephalometric radiography lead thyroid protection is necessary if 
the beam collimation does not exclude the thyroid gland’.1 The US guidelines 
as formulated by the National Commission on Radiological Protection also 
recommend thyroid protection: ‘Thyroid shielding shall be provided for 
children, and should be provided for adults, when it will not interfere with the 
exam’.7 The differentiation between children and adults can be explained by 
the fact that children are at higher risk of detrimental effects of radiation per 
administered dose.6 
The majority of persons undergoing orthodontic treatment are children, and 
the prevalence of orthodontic treatment is high in westernized societies.8 
Several cephalograms are usually taken during orthodontic treatment.9 These 
exposures individually result in a low dose of 5–10 µSv when using modern 
X-ray equipment, but the high number of these exposures together adds up 
to a considerable collective dose.10,11 This is considered to be a significant 
potential health issue.12 In their 2013 policy statement “Thyroid shielding 
during diagnostic medical and dental radiology”,13 the American Thyroid 
Association suggests a connection between the rise in the radiation burden of 
the thyroid gland and the rising prevalence of thyroid cancers. The American 
Thyroid Association recommends that efforts should be made to encourage 
and monitor  compliance with medical and dental guidelines with respect to 
shielding the thyroid gland.13 
Thyroid collars (TCs) to shield the thyroid gland during lateral cephalography 
were first introduced by Block et al14 in 1977 and are readily available. 
Wiechmann et al15 have investigated the utility of TCs and concluded ‘TCs 
should be routinely applied during cephalometric radiography if cephalometric 
analyses are limited to structures above the second cervical vertebra’. In 
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2011, Sansare et al16 came to a similar conclusion that TCs should be used 
unless information on the morphology of the cervical vertebrae is needed to 
perform a skeletal maturity index (SMI). SMI was introduced by Hassel and 
Farman17 as an alternative to the use of hand-wrist exposures to assess skeletal 
maturation used to determine timing and possibilities for growth modification 
of orthodontic treatment. It was further developed and popularized by Franchi 
et al18 from the onset of this century.19 Although the validity of the use of SMI 
is debated, it may be one of the reasons why compliance with shielding the 
thyroid gland is poor.3,20 Hujoel et al found a drop in TC use from almost 50% 
in the 1990s to as low as 10% in the beginning of this century. Hujoel et al6 
suggest that this decrease is connected to the rise in use of SMI. In the third 
edition of the guidelines of the British Orthodontic Society (2008), Isaacson 
et al21 stated that hand–wrist exposures are no longer indicated because 
cervical vertebrae could provide the needed maturation information, thereby 
discouraging the use of TCs. Recently, Patcas et al11 conducted a dose study 
in which it was shown that the effective dose (ED) of a cephalogram when 
used with a TC plus an additional hand-wrist exposure is 30% lower than that 
of a single cephalogram with the cervical area exposed. This author strongly 
advocates the use of TCs and the use of an additional hand-wrist exposure if 
evaluation of skeletal age is needed. 
The authors of this present article reasoned that resistance to shielding the 
thyroid gland would be eliminated if a device would be available that shields 
the thyroid gland without obscuring the cervical vertebrae. This could lead to 
improvement in compliance with the guidelines. To be able to justify the costs 
of such a shielding device, dosimetry is needed to establish the dose-reducing 
capabilities of the device. 
The aim of this study is to (1) present a thyroid shielding device that leaves the 
cervical vertebrae exposed during lateral cephalography and to test its dose 
reducing capabilities compared with a TC and (2) to test the dose reduction of 
the device in combination with anatomical cranial collimation.
METHODS AND MATERIALS
Design of the cephalographic thyroid protector 
For the design of the cephalographic thyroid protector (CTP), the correct 
dimensions of the shielding pad and the correct positioning of the device to 
the side of the neck of the patient had to be determined. 
The dimensions of the shielding pad were determined with the aid of lateral 
extraoral light photographs with shielding pad dummies of different sizes and 
shapes positioned on the neck of patients for whom recent cephalograms 
were available. By superimposing these light photographs with the 
cephalograms of these same patients, the optimal form, size and position of 
One possible way to reduce the dose 
for the patient is by minimizing the 
irradiated area of the patient to the region 
of interest for the diagnostic task.
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Figure 1 –  
Photographs of the cephalographic thyroid 
protector (CTP) positioned on the neck 
of a patient in a cephalostat, and the 
anatomical cranial collimator (ACC) fi xed 
to the ear post of the cephalostat viewed 
from frontal and lateral sides. On the lateral 
view, a marking can be seen that helps to 
correctly position the CTP. The marking 
should be parallel to the anterior border 
of the sternocleidomastoid muscle; the 
corner of the CTP pointing upwards should 
be in close proximity to the angle of the 
mandible.
Figure 2 –  
Lateral cephalogram made with 
cephalographic thyroid protector (CTP) and 
anatomical cranial collimator (ACC).
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a shielding pad could be determined in several iteration steps. 
The corresponding shielding pad, including a slab of 1-mm thick lead in a 
matching plastic casing, was designed using SolidWorks three-dimensional 
computeraided design software v. 2011 (Dassault Systèmes Solid-Works, 
Waltham, MA).
To stabilize this shielding pad to the side of the neck of a patient during 
image acquisition, a flexible arm was attached and fitted with a plastic neck 
rest that was on the contralateral posterior corner of the neck; these items 
together formed the CTP (Figures 1 and 2). The plastic components were 
fabricated through selective laser sintering of PA 2200 material on a dedicated 
Electric Optical System system (EOS GmbH Electro Optical Systems, Munich, 
Germany). The parts were joined and assembled with gluing and regular 
fasteners.
Dose measurements
An anthropomorphic adult RANDO® head phantom (The Phantom Laboratory, 
Salem, NY) was placed in a Proline XC device (Planmeca, Helsinki, Finland) 
with a ‘single shot’ lateral cephalometric option. To place thermoluminescent 
dosimeters (TLDs) in the phantom head, holes were drilled at 25 specific 
locations. The locations that were used are specified in Table 1. At each 
location, two solid TLD GR 200A chips (Thermo Fisher Scientific, Waltham, 
Table 1 –  
Locations of the pairs of thermoluminescent 
dosemeters.
location  tissue    location
1 skull left
2 skull right
3 brain left
4 brain right
5 orbital floor left
6 orbital floor right
7 mandibular ramus ascendens left
8 mandibular ramus ascendens right
9 parotid gland left
10 parotid gland right
11 mandibular body left
12 mandibular body right
13 submandibular gland left
14 submandibular gland right
15 oesophagus left
16 oesophagus right
17 cheek left
18 cheek right
19 thyroid surface left
20 thyroid surface right
21 thyroid intern central
22 neck (muscle) central
23 cervical vertebrae central
24 floor of the mouth central
25 skull anterior central
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MA) were placed. According to the manufacturer’s data sheet, the TLDs were 
accurate in the range of 0.1 mGy–10 Gy. To preserve the TLD chips from 
any  contamination, they were placed in polymethyl methacrylate containers. 
For transposition of the TLD, a vacuum forceps (Aspirette®; Hirschmann 
Laborgeräte, Eberstadt, Germany) was used. The total number of TLDs 
used per protocol was 50. Three additional dosimeters per protocol were 
kept apart to facilitate correction for background radiation or other possible 
unknown influencing factors. After placing two TLDs at each location, the 
RANDO phantom was reassembled and aligned in the cephalostat of the 
cephalometric X-ray unit. Great care was taken to assure that the phantom was 
positioned identically during all four protocols.
To reset and anneal all TLDs at the same time and in a reproducible procedure, 
a microprocessor-controlled TLD oven (PTW-Freiberg, Freiberg, Germany) was 
used; before the exposure, all TLDs were heated to 220°C, were kept at this 
temperature for 15 min and cooled down to room temperature. The readout 
process of the TLD was performed in a Fimel LTMWin oven (Fimel, Fontenay-
aux-Roses, France). Each TLD was placed in the oven, and the readout process 
was initialized, and the result of the process, a digit representing the detected 
radiation energy by the TLD (Adet), was displayed and stored. All TLDs were 
cross-calibrated through an exposure with a defined dose (Ddef) of 1.01x10
-5 
µGy, which was measured using a UNIDOS®E (PTW) that was calibrated at 
PTW, Freiburg, Germany (SSD Laboratory). After the readout process, the 
detected energy (Adet) was used to calculate an individual calibration factor Ki 
(Equation 1).
Ki =  
Ddef
         Adet
All individual calibration factors Ki were averaged to a mean calibration factor 
K = 3.58x10-3 [standard deviation (SD) = 1.12x10-4, relative SD (SD%) = 3.2%]. 
The evaluation of the ED was performed using four different protocols in 
lateral cephalometric mode with different shielding devices with constant 
technique factors (Table 2). 
After scanning, the RANDO phantom was deconstructed, and the readout 
process was performed immediately. 
To calculate the ED each .TXT file from the read-out process was imported to 
Microsoft® Excel®: Mac 2011 v. 14.4.4 (Microsoft Corporation, Redmond, WA). 
All calculations were also carried out using this version of Excel. 
Table 2 –  
Shielding and technique factors for the 
different protocols.
CTP = cephalographic thyroid protector
protocol shielding voltage (kV) current (mA) exposuretime (s)
1 none 80 12 50 x 5
2 CTP 80 12 50 x 5
3 CTP + anatomical 80 12 50 x 5
 cranial collimator
4 thyroid collar 80 12 50 x 5
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The technique factors used for a single exposure for an adult female in our 
institute are 80 kV, 12 mA and 0.6 s exposure time with 2.5-mm aluminum 
filtration. To obtain reliable measurements, exposures were made with 80 
kV, 12mA and a total exposure time of 250 s (50 exposures of 5 s) for every 
protocol. These selected technique factors gave an equivalent number of 
n=416.7 regular exposures (n=250/0.6). The absorbed dose at each of the 25 
locations (s) within the RANDO phantom was calculated by averaging the Adet 
of the two dosimeters of that location (Equation 2).
416.7
K x {½ x [(AdetTLD) S1 + (AdetTLD) S2 ] – AdetTLDBR}
ADSmeasured  =
where (AdetTLD)
s
1 and (AdetTLD)
s
2 are the energies detected in dosimeters 1 
and 2 at location (s), and Adet TLDBR is the energy detected by the background 
dosimeters, multiplied by the calibration factor K, divided by the number of 
regular exposures (n=416.7). 
Subsequently, to calculate the equivalent dose for the organ/tissue (Htissue), 
all absorbed doses for the locations representing one tissue were averaged. 
Which locations were used for which tissues is specified in Table 3. These 
averaged doses were corrected for the proportion of the presence of this 
tissue/organ within the exposed area in relation to the whole human body 
( tissue) as shown in Equation 3. The proportions used in these calculations are 
shown in Table 3. Both the locations and the proportion used were based on 
International Commission on Radiological Protection recommendations.22
(Equation 3).
Htissue =  tissue  x      
∑      ADSmeasured
The ED in total was then calculated using the proposed weighting factors 
ωtissue from the International Commission on Radiological Protection 103, 
published in 2007 shown in Table 3.22 The ED is the summation of the 
Table 3 –  
Tissue weighting factors and percentage 
of the tissues exposed according to 
International Commission on Radiological 
Protection (ICRP) publcations 10322 and the 
numbers of which locations (Table 1) were 
used to calculate the organ or tissue doses.
tissue ICPR tissue-weighting factors fraction irradiated (%) locations used to calculate the organ dose
bone marrow 0.12 16.5 1, 2, 7, 8, 11, 12, 23, 25
remainder tissues
– extrathoracic airway 0.12 100 5, 6, 13, 14, 15, 16, 21, 24
– lymphatic nodes 0.12 5 5, 6, 9, 10, 13, 14, 15, 16
– muscle 0.12 5 5, 6, 9, 10, 13, 14, 21, 22, 25
– oral mucosa 0.12 100 12, 14, 24
oesophagus 0.04 10 15, 16
thyroid 0.04 100 19, 20, 21
bone surface 0.01 16.5 1, 2, 7, 8, 11, 12, 23, 25
brain 0.01 100 3, 4
salivary glands 0.01 100 9, 10, 13, 14, 24
skin 0.01 5 17, 18
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equivalent doses (Htissue) multiplied by their tissue/organ-weighting factors 
(ωtissue), multiplied by the radiation weighing factor ωradiation. This radiation 
weighing factor is 1 for X-rays (Equation 4).
ED = ∑  ωtissue x Htissue x ωradiation
tissue
Error calculation
A mathematical approach to calculate error propagation of the random 
error found in the measurements of our experiments was not feasible. This is 
because the equivalent dose that is calculated for one organ in many cases 
is derived from locations that are also used for calculation of the equivalent 
doses of other organs. This means that they are not independent and that the 
rules of error propagation cannot be readily used because of these dependent 
random errors. A viable way to estimate the random error in the ED is to use 
‘Monte Carlo’ simulation. To perform this simulation, open source software 
R v. 3.0.2 (The R Foundation for Statistical Computing, Vienna, Austria) was 
programmed to exactly simulate the ED calculation algorithm used in this 
experiment. 10,000 cycles of ED calculation per protocol were simulated. 
For every single cycle, the software generated values in the calculation that 
contained random error. These values were based on the measured values 
found in the present experiment and their calculated SDs. As our data clearly 
showed a significant quadratic relationship between the relative error in the 
TLD measurements [measured as relative SD = SD% = (SD/mean) x 100%] 
and the amount of energy they detected (Adet) to p=0.001 with r
2=0.126. The 
generation of this was modelled as a quadratic function (Equation 5). 
SD% = 4.57 – 1.98 x 10 –7 x (Adet) + 3.29 x 10
–15 x (Adet)
2
Table 4 –  
Absolute and relative effective dose (ED) 
calculated for the different tissues involved.
ACC = anatomical cranial collimator
CTP = cephalographic thyroid protector
SD = standard deviation
SD% = relative SD
TC = thyroid collar
For the different tissues: ED is the 
equivalent dose (Htissue), corrected for the 
fraction of the tissue in the exposed area 
and corrected for the tissue-weighting 
factor (ωtissue)
The total ED is the summation of these 
equivalent doses of the different tissues.
 protocol 1: no shielding  protocol 2: CTP protocol 3: CTP&ACC  protocol 4: TC
 ED ED(%) ED ED(%) ED ED(%) ED ED(%)
tissue [µSv(SD)] (SD%) [µSv(SD)] (SD%)  [µSv(SD)] (SD%)  [µSv(SD)] (SD%) 
bone marrow 1.61 18.95 1.44 26.70 0.53 15.25 1.50 30.13
oesophagus 0.22 2.52 0.20 3.77 0.17 4.88 0.04 0.75 
thyroid 3.62 42.49 0.54 10.07 0.54 15.46 0.40 7.96 
bone surface 0.14 1.58 0.12 2.22 0.05 1.27 0.13 2.51 
brain 0.55 6.47 0.56 10.41 0.08 2.45 0.57 11.43 
salivary glands 0.86 10.10 0.98 18.09 0.84 24.05 0.98 19.54
skin 0.04 0.46 0.05 0.98 0.05 1.22 0.05 1.06  
remainder tissues 1.49 17.43 1.49 27.77 1.25 35.42 1.32 26.62
total ED 8.51 100.00 5.39 100.00 3.50 100.00 4.97 100.00
 (0.099) (1.16) (0.059) (1.10) (0.041) (1.18) (0.059) (1.18)
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By assessing the 10,000 ED outcomes, the SD in the ED calculation of a 
protocol could be established. These SDs were used to evaluate significance 
between the ED of different protocols (p<0.05).
RESULTS
The calculated ED for the protocols and their SDs generated by the 
simulations are displayed in Table 4. The ED without shielding was 8.51 µSv 
(SD, 0.099). The differences between the ‘no shielding’ protocol and the three 
shielding protocols are shown in Table 5. All differences between the protocols 
were significant. The organ that received the highest dose in Protocol 1 was 
the thyroid gland with 30.17 µSv. The thyroid dose was reduced by the CTP 
in Protocols 2 and 3 to 4.50 µSv (85% reduction) and in Protocol 4 to 3.33 µSv 
(-89%).  
DISCUSSION
A device (CTP) that shields the thyroid gland while leaving the cervical 
vertebrae exposed to facilitate SMI was introduced. The rise of the popularity 
of the SMI is seen as one of the reasons for not complying with the guidelines 
on shielding the thyroid from the primary beam. By making a device available 
that shields the thyroid while leaving the vertebrae visible, the compliance 
could be improved. CTP can only be considered a viable alternative when 
its dose reduction capabilities are comparable to that of a TC. In this dose 
study, it was established that dose reduction of CTP was somewhat lower but 
comparable with that of a TC. The fact that the CTP shields a smaller area than 
does the TC may explain this. 
In a recent study by Patcas et al,11 an ED reduction of 34% was found when 
the thyroid area was shielded with a TC. This is comparable to the findings in 
this study. Patcas et al strongly recommend shielding of the thyroid and the 
taking of an additional hand-wrist exposure if skeletal maturation information 
is needed. This additional hand-wrist radiograph is not necessary when using 
the CTP instead of TC. On the other hand, when no information on skeletal 
maturation is desired, the TC should be preferred because it shields a larger 
area and was found to reduce the ED more. 
When the thyroid is shielded, the further reduction of the exposed area cranial 
of the skull base with the ACC reduces the ED with an additional 35%. The 
ACC covers a larger area than does the CTP but the tissues that are shielded 
Table 5 –  
Relative differences between the four 
protocols.
CTP = cephalographic thyroid protector
 effective dose difference to difference to difference to difference to
protocol (µSv) protocol 1 (%) protocol 2 (%) protocol 3 (%) protocol 4 (%)
1 no shielding 8.51 0 +57.9 +142.8 +71.0
2 CTP 5.39 -36.7 0.0 +53.7 +8.3
3 CTP + anatomical 3.50 -58.8 -34.9 0.0 -29.6
   cranial collimator
4 thyroid collar 4.97 -41.5 -7.6 +41.9 0.0
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are less radiosensitive than those in the thyroid area. A reduction of more than 
a third is remarkable with this fixed one-size-fits-all collimator. A validation 
study of the cranial collimator revealed that relevant diagnostic information is 
not shielded when this device is used.23
The reduction of the combination of the two devices results in an almost 
60% reduction of the dose. In the literature, we find an article by Gijbels et 
al24 from 2003 where collimation of non-diagnostic areas on a cephalogram 
resulted in 40% dose reduction using a phantom head. Alcaraz et al25 also 
investigated the dose reduction collimator to be used in combination with a 
combined panoramic-cephalometric machine. They reported ED reductions 
around 60%, which is comparable to our result. Lee et al,26 using Monte Carlo 
simulation and dose measurements to evaluate a collimator similar to that of 
Gijbels et al,24 also found around 60% ED reduction. From the literature, it 
can be concluded that only 40% of the ED of a non-collimated cephalogram 
contributes to its diagnostic value. A fifth protocol to investigate the ED 
reduction of TC combined with the ACC was considered but was discarded 
because of time and financial constraints. When we consider the changes in 
organ doses caused by the shielding of the different areas in the different 
protocols, it can be deduced that the reduction of ED for the combination of 
ACC and TC would be around 65%. The reduction in the thyroid dose of 85% 
by the CTP is striking. The thyroid is the most radiosensitive organ in the head 
and neck region. As these substantial reductions can be reached without loss 
of diagnostic information, clinicians should seriously consider implementation 
of using these devices.
The relative error in the measurements was found to be small, between 1.1% 
and 1.2%. This was assessed using multiple recalculations of the ED with 
random error generated by software. As far as the authors know, this way 
of estimation of the error of dosimetric research was not carried out before. 
In order to be able to make statements on significance of the differences 
between the protocols, a valid assessment of the error in the experiment 
seems vital to the authors. This way of estimating error could also be used in 
the set-up of dosimetric studies. It could, for example, be used to decide if 
one or two dosimeters are needed per location. In the case of this experiment, 
the use of one dosimeter per location, instead of two, would have enlarged 
the error in our ED results to 1.23 – 1.35%. The error found resulted in 
significance between the ED calculated from the different protocols. The 
small error found in this experiment does not imply that the science of ED 
calculations in larger scope is very precise. The ED calculation originally was 
introduced for radiation protection purposes. More and more ED is used to 
evaluate and compare medical exposures with greater precision than the 
underlying science justifies. Martin27 states in an article on the use of the ED 
concept for medical exposures that the relative uncertainties might be around 
40%. This being the case, in a controlled experiment as in the present article, 
these uncertainties are identical for the  protocols that are compared and 
therefore not relevant for these comparisons. 
The phantom head used in this study was adult sized. The dose calculations 
made with the technique factors suggested by the manufacturer for an adult 
resulted in the reported ED of 8.51 µSv. Ideally, the study would have been 
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carried out with an adolescent or child size phantom, which was unfortunately 
not available for this study. The results for ED reduction in the same 
experiment with a child phantom can be expected to be comparable as the 
same organs are shielded. Possibly the reduction might be even greater as the 
shielding devices are covering a greater part of a child’s head. In our clinic, the 
technical factors are used with a shorter exposure time of 0.4 s for children. 
This would arbitrarily correspond to 5.7 µSv child dose without shielding. 
This is a dose that is comparable to those found in the literature.10 With the 
maximum  shielding, as in Protocol 3, this value would be reduced to 2.3 µSv. 
This is an ED comparable to that of two bitewing exposures with rectangular 
collimation. In more modern equipment than that used in the present study, 
this value could be even lower. More interesting than the absolute values 
of the exposures in this specific cephalometric unit are the relative effects. 
They imply that independent of the radiographic equipment used, whether 
it delivers a high or a low ED, this ED can be more than halved by adequate 
shielding. 
Given the fact that many cephalographic exposures are made, a serious 
reduction of the collective dose can be achieved if these shielding devices 
are generally used. Because the orthodontic patients are young on average, 
the risk of this collective dose in the form of cancer induction is higher. This 
makes the substantial reduction in ED with the shielding devices all the more 
meaningful.
In conclusion, the ED of orthodontic lateral cephalography can be more than 
halved when using the two shielding devices ACC and CTP. The shielding of 
the radiosensitive thyroid gland contributes largely to this reduction. The use 
of CTP and ACC can reduce the collective dose in a predominantly young 
population, thereby reducing risks to public health. 
The combination of the two 
devices results in an almost 60% 
reduction of the dose
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ABSTRACT 
CHAPTER 4
OBJECTIVES
To test the dose-reducing capabilities 
of a novel thyroid protection device 
and a recently introduced cranial 
collimator to be used in orthodontic 
lateral cephalography. 
METHODS
A cephalographic thyroid protector 
(CTP) was designed to shield the 
thyroid while leaving the cervical 
vertebrae depicted. Using a RANDO® 
head phantom (The Phantom 
Laboratory, Salem, NY) equipped 
with dosemeters and a Proline 
XC (Planmeca, Helsinki, Finland) 
cephalograph, lateral cephalograms 
were taken, and the effective dose 
(ED) was calculated for four protocols: 
1  without shielding; 
2  with CTP; 
3   with CTP and anatomical cranial 
collimator (ACC);  
4  with a thyroid collar (TC). 
RESULTS
The ED for the respective protocols 
was (1) 8.51; (2) 5.39; (3) 3.50; and 
(4) 4.97 µSv. The organ dose for the 
thyroid was reduced from 30.17 to 
4.50 µSv in Protocols 2 and 3 and to 
3.33 µSv in  protocol 4. 
CONCLUSIONS
The use of just the CTP (Protocol 2) 
resulted in a 36.8% reduction of the 
ED of a lateral cephalogram. This 
was comparable to the classical TC 
(Protocol 4). A 58.8% reduction of the 
ED was obtained when combining 
CTP and ACC (Protocol 3). The dose 
to the radiosensitive thyroid gland 
was reduced by 85% in Protocols 2 
and 3 and by 89% in Protocol 4.
NEDERLANDSE SAMENVATTING 
HOOFDSTUK 4
Dit hoofdstuk beschrijft de tests naar 
de dosisreducerende eigenschappen 
van een nieuwe cephalografische 
schildklierprotector (CTP) en de 
anatomische craniale collimator 
(ACC). De CTP en ACC zijn bedoeld 
om in te zetten bij orthodontische 
röntgenschedelprofielopnamen. De 
CTP is ontworpen om de schildklier 
af te schermen van de primaire 
röntgenbundel zonder afbeelding van 
de nekwervels te verhinderen. 
Met een Planmeca Proline XC 
röntgentoestel werden laterale 
schedelopnamen gemaakt van een 
RANDO-fantoomhoofd voorzien van 
dosismeters. De effectieve dosis werd 
berekend voor vier protocollen: 
1 zonder afscherming; 
2 met CTP; 
3 met CTP en ACC; 
4 met schildklier beschermende   
 loodkraag. 
De effectieve dosis voor de 
verschillende protocollen was 
(1): 8.51, (2): 5.39, (3): 3.50 en 
(4): 4.97 µSv. 
De schildklierdosis daalde van 30.17 
µSv naar 4.50 µSv in protocol 2 en 
3, en naar 3.33 µSv in protocol 4. 
Alle verschillen waren statistisch 
significant. 
De CTP (protocol 2) deed de dosis 
36.8% dalen, vergelijkbaar met de 
bescherming van een loodkraag 
(protocol 4). 
De combinatie ACC en CTP (protocol 
3) leverde een dosisdaling van 58.8%. 
Door de CTP in protocol 2 en 3 daalde 
de dosis voor de stralingsgevoelige 
schildklier met 85% en in protocol 4 
met 89%.
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Assessment of random error in phantom 
dosimetry with the use of error simulation 
in statistical software
This chapter was accepted after minor revision as: 
R.C. Hoogeveen, E.P. Martens, P.F. van der Stelt and W.E.R. Berkhout 
Assessment of random error in phantom dosimetry with the use of error 
simulation in statistical software
In BioMed Research International Volume 2015, 
http://dx.doi.org/10.1155/2015/596858
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When X-rays are used for diagnostic purposes, clinicians 
should follow the ALARA principle, which directs that the risk 
of radiation exposure to the patient should be ‘As Low As 
Reasonably Achievable.’1 When different exposure protocols can 
be chosen to perform a diagnostic task it is therefore important 
to know for the clinician which protocol exposes the patient to 
the lowest dose of radiation. However, the effective dose (E) 
of an exposure cannot be measured directly. Instead, it must 
be calculated, and the International Committee on Radiation 
Protection (ICRP) has developed a system to calculate E. In 
maxillofacial radiology, E is frequently calculated by exposing 
an anthropomorphic phantom head, which contains dosimeters 
at specified locations, to radiation.2 Using this method, the 
absorbed doses in different tissues and organs can be assessed, 
and these values can be used to calculate E by a weighted 
summation. 
Like any experiment involving measurements, this method of calculating E is 
subject to error. Errors can be classified as systematic error and random error 
(RE). Systematic error can for example originate from incorrect calibration of 
the dosimeters or from uncertainties in the tissue weighting factors. When 
research is conducted to compare different exposure protocols, systematic 
error only plays a limited role, since outcomes of dosimetry experiments of 
exposure protocols that are executed with the same equipment under the 
same conditions will all be influenced by the same systematic error(s) in the 
same way. 
 
In contrast to systematic error, RE plays a role in comparative dosimetry 
because it influences the differences measured between protocols by inducing 
an artificial difference or masking or magnifying a true difference. RE can 
be regarded as a normal distribution of values around the assumed ‘true’ 
value. RE in phantom dosimetry originates from a number of sources. These 
sources are inaccuracies in the calibration process; in the dose response of 
the dosimeters or their read out process; in the correction of background 
radiation; or in the output of the X-ray generator. These different sources of 
RE propagate in the resulting inaccuracy of the calculated E, which as a result 
will also display a normal distribution. 
 
Without a correct assessment of the size of RE, confidence intervals around 
the derived value of E cannot be calculated. Therefore, tests to substantiate 
the statistical significance of differences between protocols cannot be 
properly performed. In this case, the outcome of a study has limited value and 
statements about differences between protocols are not justified. Interestingly, 
comparative dosimetry studies have been published that provide absolute 
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dose values without specifying a confidence interval.3,4 Only some of these 
publications provided an indication of the accuracy of the dosimeter system 
used and only a few quantified and incorporated the fluctuation of the output 
of the X-ray generator in the calculations. This fluctuation is an important 
source of RE, especially in protocols with low numbers of exposure cycles.
The calculation of E from energies detected in dosimeters after X-ray exposure 
follows a complex algorithm. The RE in the measured values propagates 
therefore in a complex way to the RE in the resulting E. The propagation 
of error cannot easily be calculated using the mathematical rules of error 
propagation because a number of variables that are sources of RE are 
dependent. For example, the read out values of dosimeters of one location in 
the phantom head are used in calculating the tissue dose of different tissues. 
This dependency complicates a mathematical approach to quantifying RE of 
the resulting value of E. 
One way to address and account for RE is to simulate the measurement 
process in software used for statistical calculations. This software could repeat 
the calculations of E while introducing RE around the measured values of the 
dosimetry experiments using Monte Carlo (MC) simulation. The extent of this 
artificially induced RE should be based on the specifications of the equipment 
used and/or the actual measurements acquired during the experiment. 
When multiple cycles (e.g. 10,000 cycles) of recalculation of the algorithm 
are repeated in the software with this RE simulation, a distribution of E will 
emerge. This would provide an E that is not a single value but, instead, is 
expressed as a confidence interval around an expected value, which would 
improve the relevance of the outcomes of dosimetry studies and would 
facilitate statements about the statistical significance of differences between 
protocols.
The aim of this paper was to investigate if software simulation is practical for 
quantifying error in phantom dosimetry. We applied software error simulation 
to an existing dosimetry study, using the original study’s methods, equipment 
specifications, and results.
If no (correct) confidence interval 
is defined in dose studies, the 
outcomes cannot be used to draw 
conclusions about the patient dose
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METHODS
Dosimetry experiment
To model a dosimetry study using the software simulation, we chose ‘Dose 
reduction in orthodontic lateral cephalography: dosimetric evaluation of 
a novel Cephalographic thyroid protector (CTP) and Anatomical Cranial 
Collimator (ACC)’ by Hoogeveen et al. as an example for this article.5 Briefly, 
this study involved lateral cephalographic exposures of a phantom head 
equipped with two  thermo luminescent dosimeters (TLDs) at 25 specified 
locations. Four protocols with different shielding modalities of 50 exposures 
each (5 sec at 80 kV, 12 mA) were conducted. The TLDs were calibrated by 
exposing the phantom head to a defined dose, which was measured by a 
calibrated dosimeter, and then a mean calibration factor (CF) was calculated. 
The background radiation was corrected by leaving 3 calibrated TLDs 
unexposed during the protocol and subtracting their mean measured values 
from the read out values of the exposed TLDs. The reading and annihilation 
of the TLDs were performed by a calibrated microprocessor-controlled oven. 
The E of the 4 protocols was calculated according to the ICRP tissue weighting 
factors and the fractions of tissues exposed.2 Finally, E was calculated per one 
cephalographic exposure of 0.6 sec.
Modelling the experiment 
All of the calculations for the dose experiment were programmed in open 
source software (R version 3.0.2; The R Foundation for Statistical Computing, 
Vienna, Austria; http://www.r-project.org/) and four components of the 
experiment were defined. First, the determination of the mean CF was 
modelled by dividing the average detected energy values from the TLD 
read outs by the known calibration exposure dose. Second, the background 
correction was assessed by multiplying the CF by the average of the read out 
values of the three TLDs that were unexposed. Third, the calculation of E from 
the read out values of the TLDs was programmed by averaging the values 
of the two TLDs per location and compensating for background radiation. 
The different tissue doses were calculated by averaging the values of the 
corresponding locations and accounting for the irradiated fractions of the 
tissues. E was derived from a weighted summation of the tissue doses. Fourth, 
E for every protocol per exposure of 0.6 seconds was calculated by dividing 
the derived E by 416.7 (250 sec/0.6 sec), which was the ratio of the exposure 
dose of the phantom head in one protocol over the exposure dose of one 
cephalographic exposure.
Identifying and quantifying RE 
RE was introduced to the measurements in each of the 4 components of the 
experiment. For the software modelling, this RE was identified and quantified, 
and it was used in MC simulations to assess the RE of the resulting E. First, 
the RE of the CF was estimated to be the mean relative standard deviation 
(RSD) of the individual CF’s calculated for all TLDs.  Instead of using a fixed 
mean value, RE was added to this value to perform the MC simulation. 
Second, the RE of the background radiation was estimated for each protocol 
separately using the RSD of the 3 values for the background radiation of 
the TLDs. Again, instead of using a fixed mean background value, RE was 
added to this value to perform the MC simulation. Third, the RE resulting 
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from the TLD read out process was derived from the measured values and 
was calculated to be the RSD of the 100 values of the TLD pairs (4 protocols 
with 25 locations each). It appeared that the RSD was negatively dependent 
of the read out value: the higher the read out value, the lower the RSD. Since 
the highest TLD values weigh heavily in the calculation of E, using an average 
value of the RSD would result in overestimation of the RSD of E. In the current 
dose study, this relation was best described by a quadratic function:
RSD = 4.57 – 1.98 x 10–7 x (value) + 3.29 x 10–15 x (value)2
This formula was incorporated into the software to simulate RE around the 
TLD read out values. Finally, the last RE in this experiment originated from the 
output of the X-ray generator used for the exposure. This RE of the output 
dose was previously tested with a calibrated dosimeter and estimated to have 
an RSD of 2.4%. In this experiment, a total of 50 exposures were performed 
per protocol, so the RE of the output was calculated using the mathematical 
rules of error propagation:
RSD(50exposures) =
  1  
x      50 x (RSD(1exposure))
2
50
This RE was introduced into the model when the E of a protocols of 250 sec 
of exposure was converted to E of 1 exposure of 0.6 sec.
RESULTS
We created a software model to represent the steps needed to calculate E 
from the read out values of the TLDs and we quantified the simulated RE in 
the 4 components of the experiment. First, the RE attributed to the CF was 
the RSD of the read out value of the calibration exposure and was calculated 
to be 3.2%. Second, the RE of the background radiation correction was the 
RSD of the read out values of the TLDs that were unexposed in each protocol. 
The REs for each of the 4 protocols were calculated to be 9.5%, 4.6%, 8.6%, 
and 1.3%. Third, the RSD of the TLD read out system was defined by the 
quadratic equation in Formula 1. The SD for the lowest TLD read out value 
was 4.52% and the SD for the highest measured value was 1.67%. Fourth, the 
known RSD of the output of the X-ray generator was 2.4%. Using the rules 
of error propagation (Formula 2) for a protocol of 50 exposures, the SD was 
calculated to be 0.34%. Therefore, when converting to a single exposure, 
the E of the protocol was divided by the simulated MC value using an RSD of 
0.34% around 416.7.
The software repeated the calculation of E 10,000 times for each protocol, 
using the measurements of the dose experiment and adding the applicable 
RE. The resulting values of E and their SDs and RSDs are shown in Figure 1. 
The RSD that emerged from the simulations ranged from 1.1% to 1.2%. 
The software also generated box plots for the resulting E according to the 
4 protocols; these are shown in Figure 2.
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Figure 1 –  
Graphic representation of the distribution 
of values of E in µSv after 10.000 
calculation cycles.
ED = effective dose 
rsd = relative standard deviation
sd = standard deviation 
Figure 2 – 
Box plots of the 4 protocols generated.
MED = median; 
IQR = interquartile range; 
RAN = range
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DISCUSSION 
Dosimetry studies should include a confidence interval when presenting 
results. If no confidence interval is defined, the outcomes cannot be used to 
draw conclusions about the patient dose. Mathematical calculation of the 
propagation of error for dosimetry studies is complicated because data that 
contain RE are used multiple times in the calculations of E. In this model, 
we quantified RE in each step of the process and used simulation software 
to mimic the propagation of error generated in each step of the calculation 
of E; this proved a viable way to incorporate RE into the results. Using this 
method, a statistical test can be performed to assess the significance of 
differences between exposure protocols. This enables clinicians to make 
founded choices between exposure options.
To use this approach, the mimicking software must be programmed 
accurately. For example, the CF and its RE must be incorporated in the 
calculation in order to reflect its influence on the RE of E. In this study, the 
CF was only calculated once and then used for all 4 protocols. To assess 
the difference in E between protocols, the differences between protocols 
calculated with the same CF should be compared. Therefore, the software 
must measure the 4 protocols in 1 calculation cycle with 1 CF and register 
the differences. Otherwise, the RE of the differences between the protocols 
is overestimated. 
The dose study used for this model was performed with TLDs, but this 
method of software modelling can also be applied to studies that use other 
types of dosimeters. When the precision of the specific systems used is 
incorporated in the simulation of RE, the multiple recalculations of E deliver 
an unbiased estimation of RE. 
The dose study that was used as an example in this paper regarded a 
2D imaging modality being cephalography. The method of assessing RE 
proposed in this paper can however be used for dose studies regarding all 
imaging modalities. The dosimeters in the phantom head record radiation 
at specified sites in the phantom head. Their accuracy of recording radiation 
is  independent from the exposure modality that is deployed. In the 
modelling of the experiment however it is important to correctly incorporate 
the variation in output of the X-ray generator, which is dependent on the 
exposure modality.
The RE of the output of the X-ray generator used in the modelled 
experiment decreased from an RSD of 2.4% to an RSD of 0.34%. This 
change was due to the large number (n=50) of exposures per protocol. 
If a small number of exposures had been used, the RE in the experiment 
would have been much larger. As mentioned previously, published dose 
studies often do not account for fluctuations in the output dose of the 
X-ray generator. In one study, a single cone beam computed tomography 
(CBCT) exposure of a phantom head was used and the stated RSD was 
less than 0.5%, which is unrealistically low.3 It is also important to note that 
the grey values of images of CBCT machines have a distinct pattern during 
consecutive cycles of use, which are possibly caused by changes in the 
output of the X-ray generator.6 When a research protocol does not account 
for these changes, a systematic error can be introduced in the outcomes. 
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The simulation program modelled here can also be used in a power analysis 
when planning an experiment, such as deciding on the number of TLDs per 
location. If the dose study that served as an example for this model had been 
executed with one dosimeter per location instead of two, the RE in the final 
value of E would increase from an RSD of 1.1% to 1.2% to an RSD of 1.2% to 
1.4%. If the expected differences between the protocols are small, the lower 
RSD would result in more power to reveal these differences. Also, the effect 
that different numbers of exposures per protocol would have on the RE can be 
assessed in advance. When the expected difference in E between protocols 
can be estimated in a planned dose study, the simulation program can be used 
for a power analysis of the research protocol.
Still, a reliable confidence interval around E does not mean that the use of E 
is a precise quantification of the absolute risk for an individual patient. In an 
editorial article in Radiation Protection and Dosimetry, Martin stated: ‘for a 
reference patient there is an uncertainty of ± 40% for an 80–90% confidence 
limit for E as an indicator of the relative health risk for different medical 
procedures.’7 In this same paper, he asserted that ‘E to a reference patient 
may be used during optimisation in radiology, when comparing doses from 
different techniques (…).’9 Thus, although uncertainties exist about the dose-
risk relationship, E is an appropriate concept for the optimisation of X-ray 
practices when applied to groups of patients. When protocols are compared 
for optimisation purposes, statements about differences between protocols 
can only be made when a credible confidence interval is defined around 
the value of E for each of the protocols. The method is therefore relevant 
for clinical practice because it allows a more confident statement about 
comparison of  E allowing a more educated choice between different exposure 
protocols. Our method is not aimed at providing a more confident statement 
about dose and risk for the individual patient.
Monte Carlo
In this paper, the term ‘Monte Carlo simulation’ is applied in its original 
mathematical sense, and it refers to repeated calculations to approximate the 
probability of certain outcomes using random variables. In radiation dosimetry, 
the term “Monte Carlo simulation” is known as a method by which dosimetry 
simulations can be performed with dedicated software (e.g., PCXMC v. 2.0 
software, STUK, Helsinki, Finland). Computer phantoms are radiated with 
simulated X-ray photons and on the basis of chances of interaction of the 
photons along their path, and along the paths of electrons and photons 
that are dislodged or created by the interactions, E of an exposure can be 
calculated. The mathematical technique used in the PCXMC software is Monte 
Carlo simulation. The dosimetry experiments described in this paper are 
experiments with real anthropomorphic phantoms with dosimeters radiated 
with real X-ray photons. The computer phantoms that are used in virtual 
dose studies like those with the PCXMC software are anatomically not yet 
as detailed as physical phantoms. This is especially relevant when relatively 
small areas of the head and neck are irradiated as in dental and maxillofacial 
exposures and when collimation of specific parts of the beam is tested in 
dosimetric research. This underlines the continued relevance of phantom 
dose studies and with it the relevance of correct assessment of the confidence 
intervals around their results.
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In conclusion, credible confidence intervals for derived E values in phantom 
dose studies can be calculated by using software modelling of the experiment 
that identifies, quantifies, and incorporates all sources of RE. With credible 
confidence intervals, the statistical significance of differences between 
protocols can be substantiated or rejected. This modelling software can also 
be used for a power analysis when planning phantom dose experiments.
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ABSTRACT 
CHAPTER 5
OBJECTIVES
The aim of this study was to investi-
gate if simulation in statistical soft-
ware is practical for quantifying ran-
dom error (RE) in phantom dosimetry. 
MATERIALS AND METHODS
We applied error simulation in 
statistical software to an existing 
dosimetry study. The methods, the 
equipment specifications, and the 
measurement values of this study 
were brought into this software (R 
version 3.0.2; The R Foundation 
for Statistical Computing, Vienna, 
Austria). Also the algorithm of the 
calculation of the effective dose (E) 
was programmed. Four sources of RE 
were identified: 
1 the calibration factor; 
2   the background radiation 
correction; 
3  the read out process of the 
dosimeters and; 
4  the fluctuation of the X-ray 
generator. 
How to quantify the RE caused by 
these sources was specified.
RESULTS
The amount of RE introduced by 
these four sources was calculated 
on the basis of the experimental 
values and the mathematical rules of 
error propagation. The software was 
instructed to repeat the calculations 
of the effective dose (E) multiple 
times (n=10,000) while attributing the 
applicable RE to the experimental 
values. A distribution of E emerged 
as a confidence interval around an 
expected value. 
CONCLUSIONS
Credible confidence intervals for 
derived E values in phantom dose 
studies can be calculated by using 
software modelling of the experiment 
that identifies, quantifies, and 
incorporates all sources of RE. 
With credible confidence intervals, 
the statistical significance of 
differences between protocols can 
be substantiated or rejected. This 
modelling software can also be used 
for a power analysis when planning 
phantom dose experiments
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Dit hoofdstuk beschrijft het 
onderzoek of simulatie in software de 
grootte van de toevallige meetfout in 
het eindresultaat van dosisonderzoek 
kan bepalen. Hiervoor werd een 
bestaand dosisonderzoek ingevoerd 
in statistische software (R version 
3.0.2; The R Foundation for Statistical 
Computing, Wenen, Oostenrijk). 
De berekeningsmethode van de 
effectieve stralingsdosis op basis van 
de meetwaarden van de dosismeters 
werd in de software gemodelleerd. 
Vier bronnen van toevallige 
meetfouten werden geïdentificeerd: 
1 de kalibratiefactor; 
2 de achtergrondstralingcorrectie; 
3  het uitleesproces van de 
dosimeters;
4 de fluctuatie van de röntgenbron.
De grootte van de fluctuatie van 
deze vier bronnen werd berekend op 
basis van in het experiment gemeten 
waarden, de acceptatietestgegevens 
van het röntgenapparaat en met 
behulp van de wiskundige regels van 
de foutenvoortplanting. 
De software werd geïnstrueerd de 
dosisberekeningen meervoudig 
door te rekenen (n=10.000). Bij elke 
rekencyclus genereerde de software 
op basis van toevalligheid een 
fluctuatie rond de meetwaarden in 
overeenstemming met de bepaalde 
maat van de toevallige meetfout. 
Er ontstond een verdeling van de 
berekende effectieve doses als een 
betrouwbaarheidsinterval rond een 
verwachtingswaarde. 
Op basis van dit onderzoek is te 
concluderen dat softwaremodellering 
in statistische software inderdaad 
geloofwaardige betrouwbaarheids-
intervallen bij fantoom-dosis-
onderzoek oplevert. Daarvoor is het 
wel nodig alle oorzaken van toevallige 
meetfouten in het model te betrekken 
en deze te kwantificeren. 
Geloofwaardige betrouwbaarheids-
intervallen kunnen de statistische 
significantie van gevonden verschillen 
tussen twee opnameprotocollen 
aantonen of verwerpen. De methode 
kan ook gebruikt worden bij het 
ontwerpen van protocollen voor 
dosisonderzoek en voor statistische 
poweranalyse vooraf. 
Chapter 6
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Reducing an already low dental diagnostic 
X-ray dose: does it make sense?
Comparison of three cost-utility analysis 
methods used to assess two dental 
dose reduction measures
This chapter was published as:
R.C. Hoogeveen, G.C.H. Sanderink, P.F. van der Stelt and W.E.R. Berkhout
Reducing an already low dental diagnostic X-ray dose: does it make 
sense?
Comparison of three cost-utility analysis methods used to assess two 
dental dose reduction measures
In Dentomaxillofacial Radiology 2015; 44: 20150158
The use of X-rays for diagnostic purposes in dentistry is 
well established, although the ionizing property of X-rays 
is potentially detrimental to the patient. The harm posed 
by radiography is why the radiation protection laws and 
regulations require justification for every patient exposure. 
When an exposure is justified, it is supposed to be executed 
in accordance with the as low as reasonably achievable 
principle. ‘Reasonably’ indicates that there are limits to the 
efforts required to reduce doses. Recommendations of the 
International Commission on Radiation Protection (ICRP) 
stipulate that financial and socio-economical factors must 
be taken into account when dose-reducing measures are 
considered.1 
The dose of a dental diagnostic radiographic exposure can be expressed 
in sieverts, which is the unit used for the ‘effective dose’ (E) of a dental 
radiograph. E is a measure that was designed to express the risk of 
detrimental effects. E depends on the type of radiation and the radiosensitivity 
of the organ or tissue that receives the dose. Although the assumption has 
been debated, the field of radiation protection assumes that there is a linear 
relationship between dose and risk, even at the lowest dose levels. With the 
use of a risk factor (RF), E can be expressed in terms of total detriment, which 
means the induction of fatal cancers, hereditary effects and non-fatal cancers. 
The ICRP considers the detriment-adjusted RF to be 5.73 x 10-2/Sv for the 
average population.2 Radiation detriment is age and gender dependent, 
being higher for younger age groups and slightly higher for females. The RF 
should therefore be adjusted for specific patient groups. The RF is based on 
a multiplicative risk model, implying that a radiation exposure increases the 
existing ‘natural’ cancer prevalence by a factor, after a latency period, during 
the remaining lifetime.3 When a population Group is exposed to radiation, 
the doses to individuals can be aggregated and expressed as the collective 
dose using man-Sv as the unit. These collective doses can be converted to 
stochastic effects by the RF. In this way, a population dose can be quantified 
as the loss of the number of ‘statistical lives’. This term refers to anonymous 
fictitious members of a population and is useful for quantifying and comparing 
different risks to the public.
If a dental dose-reducing measure (DDRM) is developed, it should be 
evaluated regarding its effect in the socioeconomic perspective. However, 
no methods have been definitively identified for evaluating whether or not 
a DDRM is a sound investment. Practice guidelines encourage us to invest 
in dose-reducing measures, which include using rectangular collimation for 
intraoral radiography and limiting the field of view and shielding the thyroid 
for lateral cephalography.4,5 However, there have not been any evaluations  
that balance the costs of these measures with their utility. 
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Regarding radiological protection and risk management, there are different 
methods for performing cost–utility analysis (CUA) of dose- or risk-reduction 
strategies. One method uses the concept of the alpha value (AV). The AV is a 
monetary reference value that expresses how much money is reasonable to 
be spent for a collective dose reduction. It is expressed as € per man-Sv and 
is commonly used in the nuclear industry. AV can be used to assess the price 
of dose-reducing measures against the reduction of the collective dose. The 
Organization for Economic Co-operation and Development6 has published the 
AVs from various countries. Some countries apply a fixed AV; other countries 
use an AV that varies, depending on the remaining individual dose level, 
where a low remaining dose level results in a lower AV (Table 1). The cost–
utility of a DDRM can be evaluated by this method. The AV can be used to 
convert the dose reduction per exposure into a financial benefit per exposure. 
The minimum number of exposures needed to result in a cost-effective DDRM 
can be calculated when the price of the DDRM is known. To illustrate this: let 
us assume that a fictitious device reduces the dose to the patient of an X-ray 
exposure with 10 µSv, and the national AV is 154 € / man-mSv. This means 
that after 100 exposures with the device, the reduction of the collective dose 
to the patients is (100x10µSv=) 1 man-mSv. This reduction according to the 
AV can be valuated as €154 per exposure, the reduction can be valuated 
as (€154/100=) €1.54. Should the reducing device cost €1000, then after 
(€1000/€1.54=) 650 times of its use its costs are balanced by its benefits.
Another method of performing CUA of a DDRM is to quantify the dose 
reduction as reduced loss of statistical lives and consecutively to express 
this reduction in a monetary value by the use of the value of a statistical 
life (VSL). The VSL has been the focus of many investigations. The VSL 
can be determined by surveying people about their willingness to pay for 
specific levels of risk reduction. Another method for determining the VSL 
is to calculate an implicit VSL. The cost of an actual risk-reducing measure 
is evaluated against its actual benefits for saving lives or is evaluated by 
analysing wage–risk data from the labour market.
The concept of the VSL has evolved since it was first formulated in 1962 by 
Drèze.7 Many articles on the VSL have been published since then. A recent 
meta-analysis has shown that a wide range of VSLs can be found in the 
literature, ranging from US $0.5 to $50 million.8 The wide range has been 
partially explained by differences in the age, income, and level and type of risk 
of the study population.9,10 The type of risk being reduced also plays a role in 
No methods have been definitively 
identified for evaluating wether or not 
a dose reducing measure is a sound 
investment 
the wide range. The willingness to pay for reducing the risk of a fatal cancer 
has been found to be twice that of reducing the risk of sudden death.11 
Government bodies have incorporated the concept of the VSL into their 
policies. However, their use of the VSL to develop policy does not clarify the 
wide range in the VSL as was shown by Krupnick,12 who reported that different 
government agencies in a single country use different VSLs. Doucouliagos et 
al9 have reported that the US Environmental Protection Agency recommended 
a VSL of US $6.2 million in year 2000 prices; the Australian Department of 
Finance and Deregulation adopted a VSL of A$ 3.5 million in 2007; and the 
Department of Transportation of the United Kingdom adopted a VSL of £1.64 
million in 2009. The European Union published interim values for the VSL in 
2001, with an upper and lower estimate of €0.65 million to €2.5 million in year 
2000 prices.13 The European Union publication stipulated that a 50% premium 
should be added for reducing the risk of a fatal cancer. These numerous 
different values can be compared only after correction for exchange rates, 
inflation and differences in purchasing power, which is beyond the scope of 
this article. It is highly unlikely that a universally accepted VSL will ever be 
adopted. We conclude that an acceptable estimate of the VSL for reducing 
the risk of a fatal cancer must be somewhere in the range of €2 to €5million in 
year 2013 prices. We used that range for calculations based on the VSL in this 
study. 
We illustrate the VSL method of CUA with an example with our fictitious 
device that reduces the dose with 10µSv: the ICRP RF describes that the 
chance of a stochastic effect is reduced by 10µSv x 5.7 x 10- 2 = 5.73 x 10 -7. 
In fact this chance is the part of a statistical life that is saved by the reduction. 
By multiplying the reduced chance with the VSL, we get the monetary value 
of the reduction per exposure being (5.73 x 10 -7 x €2– €5 million =) €1.14 
to €2.85. If the device costs €1000 then the cost–utility is broken even at 
(1000/2.85 =) 351 to (1000/1.14 =) 877 cycles of use.
Table 1 – 
Published alpha values (AVs)
AVs in € man-mSv_1 of 10 countries 
provided by the Organization for 
Economic Cooperation and Development.6 
Minimum numbers of use (ṋ) were 
calculated using the AV method.
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 fixed or α-value minimum maximum ṋ for ṋ for anatomical
country that variable in € α-value in € α-value in € rectangular cranical 
published AV’s value    man-mSv-1 man-mSv-1 man-mSv-1 collimator collimator/CTP
Finland fixed 77.21   170 2590
Romania fixed 570    23 351
Netherlands fixed 433.78   30 461
USA fixed 154.3    85 1296
Switzerland fixed 2481.39   5 81
Czech Republic variable  20.08 100.39 655 9960 
Korea variable  13.13 1312.59 1002 15232
Slovakia variable  33.19 663.88 396 6026
Sweden variable  55.48 283.29 237 3605
UK variable  12.55 125.39 1048 15936
Average     365 5553
Median     203 3097
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The use of the VSL to put a price on a human life is not very elegant, difficult 
to explain to the general public and can be viewed as unethical.14 To overcome 
the problem of placing a monetary value on human lives, Lind15 proposed an 
alternative method in 2002 for performing a CUA of a resource used to reduce 
risk for the public. He proposed the ‘invested time theory of acceptable 
risk’. The theory is based on the assumption that a risk-reducing measure is 
beneficial to a community when the number of years of healthy life expectancy
is greater than the years spent working to pay for the measure. Lind’s theory 
will be referred to in this report as the ‘time-for-time’ principle. The time-for-
time principle can be used for CUA of a DDRM by converting the reduced 
loss of statistical lives to reduction of lost lifetime (LLT). The reduced LLT per 
exposure can be compared to the working time (WT), which is equivalent to 
the investment for the DDRM, to determine the minimum number of times the 
DDRM must be used to become cost effective.
To illustrate this method of CUA, we use the example that was given for the 
VSL method where 5.73 x 10-7 statistical lives were saved per exposure. When 
assume that per stochastic effect 15 years of life lost, this amounts to a saved 
lifetime of 8.6 x10-6 years per exposure. The time it costs to work for earning 
the device can be calculated by dividing the price (say €1000) by the average 
income of a worker (say €30,000 / year) corrected for the part of life we spend 
working (1/8). This gives 4.2 x 10-3 years. After a minimum number of (4.2 x 
10 -3 /8.6 x10-6 =) 484.5 cycles of use, the lifetime saved by the device is more 
than the time it cost to work for it.
To establish a standard for performing a CUA of a DDRM, the dental 
profession should identify a suitable CUA method. The aim of this study 
was to evaluate the applicability of the three CUA methods described in the 
Introduction section to DDRMs. The three methods were used to determine 
Figure 1 – 
Rinn Universal Rectangular Collimator 
(RC; Dentsply Ltd, Addlestone, UK).
the minimum number of exposures performed with the DDRM that is needed 
for the DDRM to be cost effective. If the expected number of exposures 
performed with the DDRM is higher than the minimum number of required 
exposures, the investment in the DDRM can be regarded as sound from a 
cost–utility perspective. By comparing the outcomes of the three methods 
for coherence (values for comparable countries are in the same range) and 
adaptability (the CUA can be adapted to the characteristics of the patient 
population for whom the DDRM is applied), the value of a CUA method used 
to evaluate a DDRM can be established. 
METHODS AND MATERIALS 
Two DDRMs, rectangular collimation for intraoral radiography and reduction 
of the fi eld of exposure during cephalography for orthodontic diagnostics, 
were subjected to three types of CUA. The use of a Rinn Universal Rectangular 
Collimator (RC; Dentsply Ltd, Addlestone, UK) was analysed (Figure 1). The 
Rinn RC reduces the round 6 to 8 cm diameter fi eld of exposure delivered by 
an intraoral radiography unit to a 4.5 by 3.5 cm rectangular fi eld. Ludlow et al16 
reported that the effective dose E of an average round, collimated intraoral 
exposure was 9.5 µSv, and a RC led to an 80% decrease in E (1.9 µSv), a 
reduction of 7.6 µSv per exposure. The cost of RC was determined from three 
different suppliers and was found to be approximately €100. The fact that the 
use of RC can lead to loss of diagnostic information through cone cutting and 
that, in a certain percentage of exposures, this leads to retakes has not been 
incorporated in the calculations in this article. 
Reduction of the fi eld of exposure during cephalography for orthodontic 
diagnostics can be achieved using two devices, the anatomical cranial 
collimator (ACC) and the cephalographic thyroid protector (CTP) (both 
GentleCeph BV, Rotterdam, Netherlands) (Figure 2). The ACC and CTP shield 
the thyroid gland and reduce the size of the irradiated area outside the 
diagnostic target during orthodontic lateral cephalography. These devices 
reduce the E of a lateral cephalographic exposure by 58.8% (from 8.5 to 3.5 
Fig 2 –
Reduction of the fi eld of exposure during 
cephalography for orthodontic diagnostics 
can be achieved using two devices, the 
anatomical cranial collimator (ACC) and 
the cephalographic thyroid protector 
(CTP) (both GentleCeph BV, Rotterdam, 
Netherlands). 
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µSv), which is a reduction of 5.0 µSv reduction per exposure.17 The combined 
cost of ACC and CTP was estimated by the manufacturer to be approximately 
€1000. 
Alpha value cost–utility analysis
The reduction per exposure (∆Sv) was multiplied by the AV (a) to determine 
the monetary value of the reduction per exposure. The cost of the DDRM 
(c) was divided by the monetary value of the reduction per exposure to 
determine the minimum number ( ) of use cycles required to reach the break-
even point of cost effectiveness. [Equation (1)]
n =
c
( ΔSv .  )
Table 1 shows the AVs of 10 countries. Calculations were performed using the 
AV of each country. A fixed AV is used in some countries, and some countries 
have a maximum and minimum AV, depending on the remaining risk for the 
exposed population. Because of the low remaining dose of dental X-ray 
procedures, the minimum AVs were used for the calculations. 
Value of statistical lives cost–utility analysis 
The reduction in loss of statistical lives was determined by multiplying the dose 
reduction by the RF. The RF was adjusted to the age of the exposed patient 
population (RFadj). To assess the RC, the average age of the population can be 
assumed (the ‘standard’ ICRP value of 5.7%/Sv) because intraoral radiography 
is performed for patients of all ages. To assess the ACC and CTP, the average 
age of the orthodontic population was arbitrarily set at 12 years, which results 
in a higher RF. By interpolating the data from the ICRP 60 for children aged 
12 years, the RFadj for the orthodontic patients group was determined as 
being 17.5%/Sv. The reduction in loss of statistical lives was multiplied by the 
VSL to determine the monetary value of the dose reduction per exposure. As 
reported in the introduction, the VSL values of €2 and €5million were used for 
the calculations. The cost (c) of the DDRM was divided by the monetary value 
of the reduction per exposure to determine  [Equation (2)].
n =
c
ΔSv . RFadj . VSL
Time-for-time cost–utility analysis 
The reduction of loss of statistical lives was expressed asreduction of LLT. 
Land and Sinclair18 calculated that the LLT per stochastic effect (LLT/SE) was 
15 years for a population of average age. This value will be used for the CUA 
of RC. The LLT/SE for the younger orthodontic patients with an average age 
of 12 years can be assumed to be higher than that for the RC population. 
The difference in LLT/SE between these populations is not as large as the 
difference in their average age would suggest. According to the multiplicative 
model, the radiation risk increases the existing risk of cancer by a factor. 
Because the incidence of cancer increases with increasing age, only with 
increasing age the extra stochastic effects will occur. This means that the 
stochastic effects also for the orthodontic population occur relatively late 
in life. It seems justifiable for this reason to use a value of 20 years for the 
adjusted LLT/SE of the orthodontic population.
The reduced LLT (∆LT) per use of the DDRM was determined using the 
adjusted RF and the adjusted LLT/SE [Equation (3)].
ΔLT = ΔSv . RFadj . LLT/SEadj
The cost of a DDRM (c) was expressed as the WT required of an average 
worker to pay for the DDRM. The WT was determined by dividing c by GNIc 
divided by the fraction of lifetime that was spent working (f) [Equation (4)]. To 
take into account the regional differences in economies, two values for GNIc, 
for high income economies and for upper-middle income economies, were 
used to calculate  19 (Table 2). The value 1/8 for f is used as substantiated by 
Lind.15 [Equation (4)].
WT = 
c
GNIc
f
(   )
To determine , WT was divided by ∆LT [Equation (5)].
When in Equation (5) WT is replaced following Equation (4) and ∆LT is 
replaced as Equation (3) specifies, we can rewrite Equation (5) as [Equation (6)].
n =
c . f
GNIc . ΔSv . RFadj . LLT/SEadj
The three methods were compared by assessing coherence and adaptability. 
The coherence of a method was positive if it produced comparable results 
in for comparable economic regions. If a difference between the results was 
a factor less than two, the method was graded positive for coherence, a 
difference of 2–10 was mediocre (±), and >10 was negative. Adaptability was 
assessed in terms of RF (was it possible to adjust the RF to that of the exposed 
patient population?) and in terms of LLT/SE (was it possible to adjust the value 
for LLT/SE to the age of the patient population at exposure?).
Table 2 –
World Bank data for gross national income 
(GNI) per capita of two economic regions.
The GNI er capita was converted from US$ 
to € using the exchange rate of July 2013
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 number number GNI per 
 of of inhabitants capita
region countries (2013) (billions) (2013) (€)
high income economies 31 1.054 34,257
upper-middle income economies 55 2.409 5850
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RESULTS
Alpha value method
The minimum numbers of use (  ) of the two DDRMs are shown in Table 1, 
and ranged from 5 to 1048 for RC (average 365, median 203) and from 81 to 
15,936 (average 5553, median 3097) for the ACC/CTP; an almost 200-fold 
difference between the lowest and highest value.
Value of a statistical life method
The values for  for the two DDRMs for VSLs of €2 million and €5 million are 
shown in Table 3. The  values for RC ranged from 46 to 115, and for ACC/ 
CTP from 229 to 571. There is a 2.5-fold difference between the low and high 
values, which is the same as the difference between €2 million and €5 million. 
Time-for-time method
The values for  for the two DDRMs that were calculated for high income 
economies and upper–middle income economies are shown in Table 4. The 
 values for both DDRMS differed between the economic regions by a factor 
of 5.9, which is the ratio of the GNIc of the two economies.
Comparison of methods
The results of the evaluation of the three methods for coherence and 
adaptability to a specific patient Group are summarized in Table 5. The AV 
method was negative for coherence, and for adaptability to Group specific RF 
and LLT/SE; the time-for-time method was positive for all three parameters; 
and the VSL respectively.
Table 3 – 
Minimum number of uses determined by 
the VSL method.
ṋ = minimum numbers of use
VSL = value of a statistical life
Table 4 – 
Minimum number of uses determined by 
the time-for-time method.
ṋ = minimum numbers of use
Table 5 –
Coherence and adaptability of the three 
methods of cost-utility analysis.
ṋ = minimum numbers of use
Grades of the three methods in three 
domains
device ṋVSL 2 million € ṋVSL 5 million € 
rectangular collimator 115 46
anatomical cranial collimator / 571 229
cephalographic thyroid protector 
 ṋ upper-middle ṋhigh income
device income economies economies
 
rectangular collimator 329 56
anatomical cranial collimator / 1221 209
cephalographic thyroid protector 
  coherence   adaptability
 relative range  for risk for lost lifetime per
method factor of  ṋ grade factor stochastic effect
 
alpha value 198.0 - - -
value of statistical life 2.5 ± + -
time-for-time 1.0 + + +
DISCUSSION
The guidelines for dentists and dental specialists recommend measures 
to reduce the dental diagnostic X-ray dose to their patients. They are 
not required to reduce at all costs; the effort must be to reduce as low as 
‘reasonably’ achievable. Dental X-ray doses are generally lower than in other 
fields of medicine. The question arises whether the effort to reduce an already 
low dose is worthwhile. To answer this question, the dental community should 
decide on a method for performing CUA. In our study, we evaluated three 
CUA methods that were used to analyse two types of DDRMs. The results 
of our comparison of the methods of CUA indicated that the time-for-time 
method was best suited for performing the CUA, because of positive grades 
for all the factors used for comparison. The method is coherent because it 
determined comparable outcomes for comparable countries. The AV method 
was negative regarding coherence because comparable countries used very 
different AVs. The AV method should not be used for CUA because of the 
varying and apparently random AVs used by different countries. The VSL 
method is problematic because VSL is not an officially adopted
value. The ‘official’ VSL varies between comparable countries and even 
between different governmental bodies. Therefore, in our study we used a 
range of VSL’s to perform our assessment of the method, which led to a range 
of  values. 
The VSL and the time-for-time method had positive grades for adaptability, 
because they can adjust for the characteristics of a patient group. The RF 
could be adjusted according to age and gender. The time-for-time method is 
more versatile, because it can also adjust the LLT/SE according to a specific 
patient group. The time-for-time method of CUA enables a sound basis on 
which to decide if a dose-reduction measure is cost effective. For example, 
for a decision on developing a new intraoral sensor that reduces the E by 1 
µSv per exposure, while costing €3000 more than a conventional sensor, the 
minimum number of uses before this extra investment becomes sound can be 
calculated, given the GNIc of the location and the characteristics of the patient 
group. In a high income economy for the average population, this new sensor 
would become cost effective after more than 12,800 cycles of use which in 
most dental offices seems as an unrealistic high number. 
For another example, the time-for-time method can also be used to establish 
that a certain cost-effective measure for a paediatric dentistry clinic will not 
be cost effective for a geriatric dentistry clinic because of differences in 
the RF and LLT/SE for these different populations. For a final example, the 
time-for-time method can be used to recommend dose-reduction measures 
for locations where certain exposures are frequently performed, and to 
decide that they would be ineffective for locations where they are used less 
frequently. 
The final example also illustrates the point that policies regarding radiation 
protection should not be based solely on CUA. Practitioners performing low 
numbers of exposures might argue that they can deliver a high radiation 
dose to their patients because investments for reducing the dose are not cost 
effective for their practice. This is where ‘dose reference levels’ should play a 
role to eliminate the outliers.2,20,21 These reference values, together with the 
CUA, must be used by governing bodies to produce regulations and practice 
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guidelines for establishing minimal standards; a CUA by itself is not enough.
The CUA methods in our study were evaluated for dental X-ray exposures, 
because large numbers of low dose exposures are performed in dentistry, 
and the available dose-reduction measures must be evaluated for cost 
effectiveness. There is no particular reason why the time-for-time method 
cannot be used for medical diagnostic radiology. The radiation doses are 
higher, but so are the costs for dose reductions. For instance, evaluations of 
dose-reducing measures for mammography obviously must take into account 
the patient group, which consists of females of a specific average age. The 
age and gender of this group can be used to determine the adjusted RF. The 
method also allows adjustment of the LLT/SE for this group, which means that 
the time-for-time method can provide data for a well founded CUA.
CUA with the time-for-time method should be regarded with some 
restraint as it is based on three assumptions. The first assumption is that 
of the linear no-threshold theory (LNT). The LNT states that there is a 
linear connection between radiation dose and risk, even at the lowest 
dose levels. This assumption continues to be debated, but until the LNT is 
proved to be incorrect, it remains the basis of our radiation protection laws 
and regulations.22 Therefore, developing a method for CUA based on this 
assumption seems valid. The second assumption is that of the accuracy of 
the use of RFs. Martin22 reported that the relative uncertainty of the use of 
RF might be as much as 40%. As the use of RFs is the established way of 
estimation risk resulting from radiation exposure, it seems logical to use them 
for CUA. The third assumption is that the timefor- time method is correctly 
based on the concept that lifetime gained by the reduction of risk must 
be more than the time society has to work for it. Lind15 states that the risk-
reducing measure is effective when the ratio of extra years of life to the extra 
years of work to pay for the measure is greater than unity. If not, he states 
that ‘the life-saving project is actually a life-consuming project’. Although this 
assumption is probably intuitively valid, it carries the perception that time 
spent on working is per se something to be regarded as negative. Perhaps 
this is true for workers with little education, possibly for a majority of workers, 
but certainly not for all, as for instance, the time spent working on this study 
is perceived as time well spent. Based on data on job satisfaction and other 
non-material rewards of employment, the time-for-time ratio of unity could be 
perceived to need adjustment. If the ratio, for example, should be changed in 
a way that lifetime gained can cost twice the amount of time to work for it, a 
risk-reducing measure would be considered cost effective at half the number 
of uses. 
Cost effectiveness of tested devices
Comparison of the three methods of CUA used to assess RC revealed that 
most results were comparable (Tables 1, 3 and 4). The median outcome of the 
AV method was in good agreement with the VSL €2M calculation and results 
of the upper-middle-income economies determined by the time-for-time 
method. The results of the time-for-time CUA for the high income economies 
and the VSL method using €5M for calculations were very close for both 
DDRMs. Equations 2 and 6 both provide the same results when VSL= {(LLT/SE) 
x GNIc}/f. The time-for-time method implicitly assumes a VSL of €4.1million 
for the average population in a high income economy, which explains the 
comparable outcomes of the two CUA methods. The CUA with VSL method 
and the time-for-time method determined that RC is effective after a realistic 
number of uses in a general practice. These methods also regard ACC/CTP 
effective after a few hundred uses, which seems to be a realistic number for an 
orthodontic office. The CUA with the AV method regards both DDRM effective 
after a realistic number of uses when the AVs are used of the countries with 
a single AV. The low AVs used in the countries with variable AV results in 
unrealistic high numbers of use before the DDRM are considered effective. 
These low AVs are remarkable as they do not seem to be in accordance with 
generally accepted principles of radiation protection, more specific with the 
LNT. The low AVs are specified to be applicable in case of low remaining dose 
levels for the individual member of the public. The medical X-ray burden of 
populations in modern societies is high and rising. In 2006, 48% of the total 
population dose in the USA was caused by medical exposures.23 Therefore, it 
could be argued that the remaining dose level for the individual member of 
the public is not that low, and a higher AV should be applied. The results of 
the CUA with the AV method for these countries could then be more in line 
with the other CUA methods.
The benefits of dose reduction lie far in the future, as only then reduction in 
cancer incidence will become evident. Therefore, the cost of a dose-reduction 
measure precedes its utility. It could be argued that financing costs should 
be incorporated into the CUA. A contrary view is that the financing costs are 
the same as the increase in GNIc until the benefits materialize, and that they 
should therefore not be incorporated. This shows that we are comparing 
unequal properties. Money can be saved and can earn interest, but no returns 
can be calculated for preserving health in the future.
In conclusion, the time-for-time CUA method was found to be superior in 
coherence and adaptability to two other CUA methods. A simple formula 
can be used to determine the minimum number of uses for a dose reduction 
measure to become cost effective. This method can allow a valid assessment 
of the cost effectiveness of investments in dose-reduction devices. The CUA 
with the time-for-time as well as the VSL method in this study of two DDRMs 
showed that they were cost effective after a realistic number of uses.
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ABSTRACT CHAPTER 6
OBJECTIVES
To find a method that is suitable for 
providing an objective assessment 
of the cost effectiveness of a dose-
reducing measure used for diagnostic 
dental X-ray exposures. 
METHODS
Three cost–utility analysis (CUA) 
methods were evaluated by 
comparing their assessments of 
two dose-reduction measures, 
a rectangular collimator and 
the combination of two devices 
that reduce the radiation dose 
received during orthodontic lateral 
cephalography. The following CUA 
methods were used: 
1  The alpha value (AV), a monetary 
valuation of dose reduction used in 
the nuclear industry; 
2  The value of a statistical life for 
valuation of the reduction in 
stochastic adverse effects; and 
3  The time-for-time method, based 
on the postulate that risk reduction 
is effective when the number of 
years of life gained is more than the 
years that an average worker must 
work to earn the costs of the risk-
reducing measure. 
The CUA methods were used to 
determine the minimum number of 
uses that was required for the dose-
reducing device to be cost effective. 
The methods were assessed for 
coherence (are comparable results 
achieved for comparable countries?) 
and adaptability (can the method 
be adjusted for age and gender of 
specific patient groups?). 
RESULTS
The performance of the time-for-
time method was superior to the 
other methods. Both types of dose-
reduction devices tested were 
assessed as cost effective after a 
realistic number of uses with all three 
methods except low AVs. 
CONCLUSIONS
CUA for the methods of X-ray 
dose reduction can be performed 
to determine if investment in low 
dose reduction is cost effective. The 
time-for-time method proved to be 
a coherent and versatile method for 
performing CUA
NEDERLANDSE SAMENVATTING 
HOOFDSTUK 6
Dit hoofdstuk beschrijft het 
onderzoek naar een objectieve 
kosten-batenanalyse (KBA) 
voor tandheelkundige 
stralingsdosisreducerende 
maatregelen bij diagnostische 
röntgenopnamen. Hiervoor werden 
drie verschillende KBA-methoden 
beoordeeld door de uitkomsten 
van deze methoden voor twee 
dosisverlagende maatregelen 
te vergelijken: de rechthoekige 
collimator voor intra-orale 
röntgenopnamen en de ACC en 
CTP (zie eerdere hoofdstukken) voor 
röntgenschedelprofielopnamen.
De volgende drie KBA werden 
onderzocht: 
1 Alpha Value (AV)
  AV is een geldelijke waardering 
voor dosisreductie die toegepast 
wordt in de nucleaire industrie. 
2 Waarde van een statistisch leven 
  Dit is een financiële waardering 
van een mensenleven gebruikt in 
risicomanagement.
3 Tijd-voor-tijdmethode
  Deze methode is gebaseerd op de 
stelling dat een risicoreducerende 
maatregel effectief is wanneer de 
  gewonnen levensduur in tijd meer 
is dan de tijd die een gemiddelde 
werker nodig heeft om de kosten 
voor deze maatregel terug te 
verdienen. 
De KBA’s werden gebruikt om 
te berekenen hoe vaak een 
dosisreducerende maatregel 
minimaal gebruikt moet worden om 
kosteneffectief te zijn. De methoden 
werden beoordeeld op coherentie 
(worden vergelijkbare resultaten 
gevonden in vergelijkbare landen?) 
en aanpassingsvermogen (kan de 
methode rekening houden met 
leeftijd en geslacht van specifieke 
patiëntengroepen?).
De tijd-voor-tijdmethode blijkt 
superieur ten opzichte van de andere 
methoden. Bij beoordeling met alle 
drie de KBA-methoden blijken beide 
dosisreducerende maatregelen in 
dit onderzoek kosteneffectief na 
een realistisch aantal keren gebruik, 
behalve bij lage AV-waarden. 
Concluderend kan worden gesteld 
dat met KBA getoetst kan worden of 
het kosteneffectief is om een toch al 
lage dosis verder te verlagen. De tijd-
voor-tijdmethode heeft zich bewezen 
als een coherente en aanpasbare 
methode voor KBA. 
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X-rays are potentially hazardous because of their ionising nature. 
If damage to the DNA caused through ionising radiation is not, 
or not correctly repaired, the damage may eventually result in 
the development of a tumour.1 This process of tumour induction 
knows a latency period ranging from 6 to more than 20 years.2 
The probability of a tumour developing is dependent on the 
X-ray dose; that is, on the radiation energy absorbed by the 
tissues. It is a chance effect and because of this it is called a 
stochastic effect. Some tissues are more sensitive to radiation 
than others and children are more prone to these stochastic 
effects than are adults.3 The organ most sensitive to radiation in 
the head and neck area is the thyroid gland.4 The International 
Commission on Radiological Protection (ICRP) has developed 
a system to calculate the risk of the patient of developing a 
tumour as a consequence of a certain radiation dose. This dose 
is known as the ‘effective dose’ and is expressed in the unit 
Sievert (Sv). The risk of experiencing the stochastic effect of 
tumour induction in an average person of 30 years of age is 
5%/Sv. However, for children around the age of 10 this risk is 
approximately 3 times greater.3 
The radiation dose to the patient of an orthodontic lateral cephalogram 
(Ceph) is relatively low, in the order of 5 to 10 millionths of a Sievert (5-10 
µSv).5 This means therefore that the individual patient risk is also low. For 
a child undergoing orthodontic treatment, applying the age adjusted ICRP 
risk factor, this stochastic risk can be calculated to be around 1 in 700,000 
per Ceph. However, as is the nature of stochastic effects, when a small risk is 
incurred many times, to arrive at the total risk each of these risks are added. 
Because many children undergo orthodontic treatment, and during the course 
of this treatment usually one or more Cephs are made, the consequential 
collective X-ray burden can be considerable, resulting in an increase of the 
incidence of cancer in the population. For these reasons it is worthwhile to 
investigate measures to lower the radiation dose of Cephs, even this dose 
being already comparatively low.
To avoid unnecessary exposure of the population to ionising irradiation, the 
ICRP has developed a framework of radiological protection principles.3 This 
framework consists of three items: (1) the requirement for justification of 
exposures; (2) the ALARA (‘as low as reasonably achievable’) dose principle; 
and (3) dose limits for workers. The first principle urges clinicians to make 
sure the radiation exposure is justified, meaning that the exposure will result 
in a benefit to the management of the patient outweighing the risk of the 
exposure. Routinely performing lateral cephalography without a justifiable 
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benefit to the patient’s management should be strongly discouraged. Indeed, 
the question ‘does cephalography contribute positively to the treatment 
outcome?’ requires consideration. Some studies have found cephalography 
to have a minimal influence on the treatment plan, while other researchers 
have found the contrary.6,7,8 However, it should be noted that cephalography 
can also play a role during treatment, in the evaluation of treatment results 
and growth by means of comparing consecutive cephalograms. The mere 
fact that a treatment plan is often the same with or without cephalography 
does not therefore necessarily support the conclusion that the availability of a 
Ceph is not beneficial for the patient in terms of the total treatment outcome. 
However, when there is no anticipated benefit for the patient, then clearly the 
way to reduce patient dose is to abstain from performing a Ceph. 
Orthodontic textbooks, postgraduate curricula and post-academic courses, 
devote considerable space to this area of orthodontic diagnosis. In the early 
days of cephalometry the cephalometric normal values were used to ‘treat 
to the numbers’, thereby believing that it was possible to fit every patient 
into the same ideal template. This belief has now changed in a pragmatic 
way in which different elements of diverse cephalometric analysis are used to 
guide clinical treatment decisions.9 When a treatment does not progress as 
anticipated, the comparison of a progress Ceph with the initial Ceph can help 
to determine what happened and how to adjust and proceed. But if no initial 
Ceph was taken this option is not available. Performing a Ceph at the end of 
orthodontic treatment, is justified only in those cases where it is expected that 
the diagnostic information will benefit the clinical management of the patient 
after the treatment. 
The second radiation protection principle, i.e. the principle of ALARA (‘as low 
as reasonably achievable’) leads the clinician to choose exposure parameters 
such as exposure time, tube current and tube voltage on an individual basis 
in order to acquire the desired diagnostic information at the lowest dose 
Figure 1 – 
Lateral cephalogram without collimation 
showing cephalometric analysis using only 
a limited area of the image.
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to the patient reasonably possible. ALARA also means limiting the field of 
view to the area where the relevant diagnostic information is to be found. 
In considering the total field of view of the Ceph, it can be seen that the 
diagnostic information is in fact found within a limited area of the image. 
This information is usually retrieved with the use of cephalometric analysis. 
This analysis utilises the identification of landmarks, the drawing of lines and 
measurement of angles and distances.9 These measurements in an individual 
patient are compared with normal values, to obtain information used to plan 
the treatment. The landmarks are found in the area of the skull base and the 
jaw bones, and on the soft tissue facial profile. It can be observed that the area 
depicted on a Ceph is often larger than this area of interest. (see figure 1)
Figure 2 – 
Lateral cephalogram showing the use 
of a thyroid collar around the neck of 
the patient and in the upper part of 
the image a prototype of ten anterior 
cranial collimator (ACC).
Figure 3 – 
Wedge formed collimator.
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This has lead researchers to investigate whether the field of view of the Ceph 
can be limited. A thyroid collar was introduced to shield the area of the 
thyroid and proved to be effective.10 (see figure 2) In an attempt to not only 
shield the thyroid but also the area above and behind the skull base, so-called 
wedge-formed collimators have been proposed; these are intended to shield 
the area above the skull base and below the mandible where the thyroid is 
found.11,12,13,14,15,16 (see figure 3) From studies on wedge-formed collimation, it 
has been estimated that the diagnostic information on a Ceph can in fact be 
acquired with 40% of the conventional dose to the patient when diagnostically 
uninteresting areas are blocked. However these wedge-formed collimators 
appear to be impractical. One reason is that because the area under the 
mandible is so variable; shielding a fixed area in this region may result in 
eliminating diagnostic information in a patient with a low-positioned mandible, 
while in a small patient the thyroid is still irradiated. Another problem is that 
wedge-formed collimators were intended for use in dedicated cephalometric 
installations. In such settings, the beam could be collimated at a position 
between the x-ray generator and the patient. The modern-day X-ray units 
that are in use in orthodontic offices however are combined panoramic-
cephalometric machines and it is not possible in these machines to place a 
collimator halfway between the generator and the patient. We realised that 
instead of trying to collimate the two regions with one device, it would be 
more feasible to shield them with two different devices. The literature shows 
that the cranial area can apparently be shielded by collimating a fixed area. 
The area under the mandible in our concept has to be individually collimated 
for every patient.
Figure 4 – 
Lateral cephalogram showing use of ACC.
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CRANIAL COLLIMATION
Therefore in Chapter 2 of this thesis an anatomically-formed cranial collimator 
(ACC) for the area above and behind the skull base for lateral cephalography 
is introduced. (see figure 4) Derived from measurements of 100 Cephs, an 
outline for this collimator was established in such a way that it collimates a 
maximal area with only a remote chance of blocking anatomical structures that 
are of diagnostic interest. It was designed to be fixed to the ear post of the 
cephalostat between the X-ray generator and the head of the patient. It can 
be fitted to every existing modern X-ray unit by using make and type specific 
adaptors. On the basis of data acquired by analysing the 100 Cephs, the variability 
of the lateral projection image of the skull base relative to the external acoustic 
meatus appeared to be very small. This is because after the age of 7 years the 
skull base is no longer an active growth site.17 This means that collimation with 
a fixed form based on the anatomical data can be used for every patient. The 
patient group on which this conclusion was drawn was a group of orthodontic 
patients from a predominantly Caucasian population. In Chapter 3 of this thesis 
the ACC was tested on a specific X-ray machine, in an observer study evaluating 
100 Cephs made with the ACC. The results showed that there was minimal 
interference of the ACC on the diagnostic value of the cephalography, while 
reducing the irradiated area of the patient by almost one third.
According to clinical guidelines, shielding the thyroid from the primary beam 
in lateral cephalography is mandatory, unless it interferes with the depiction 
of structures of diagnostic interest.18,19 When a thyroid collar is used for this 
purpose it has been shown that the bodies of the cervical vertebrae below 
C2 are not depicted.20 (see figure 2) The depiction of these cervical vertebrae 
assists orthodontic clinicians in calculating the maturation index which in turn 
can help to choose the optimal timing for orthodontic treatment.21,22,23 This 
so-called cervical vertebral maturation index (CVM) is an alternative to the 
hand-wrist radiogram. Although the validity of the CVM is debated in the 
literature, it is widely used. Hujoel states that the use of thyroid collars 
probably declined when the use of CVM began to spread.24 The advantage 
Figure 5 – 
Drawing of the application 
of the CTP.
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of performing a CVM is that it makes additional hand-wrist radiography 
unnecessary.25 R. Patcas has written a very interesting paper in which he 
questions the use of the CVM, considering that the extra dose for the patient 
without the thyroid shielding is much greater than the dose for the hand-wrist 
exposure.26  Contrary to what one might intuitively assume, Patcas proves that 
it is preferable to take two X-rays, a Ceph with thyroid shielding and the hand-
wrist radiograph, compared to one exposure with the thyroid gland exposed. 
In an unpublished survey of 53 orthodontic clinicians, we found that in the 
Netherlands thyroid collars are hardly ever used and that over 80% of these 
clinicians desired depiction of the cervical vertebrae to perform the CVM. 
THYROID SHIELDING
Following this line of thought, in Chapter 4 of this thesis the design of a 
thyroid shielding device for lateral cephalography is presented which leaves 
the cervical vertebrae depicted (see figure 5). The aim of this device, referred 
to as cephalographic thyroid protector (CTP), is to increase compliance with 
the guidelines by shielding the thyroid gland without interfering with the 
diagnostic value of the cephalogram by blocking the cervical vertebrae. In 
this chapter a phantom dose study is presented that compares the effective 
dose of four protocols. It shows that using ACC and CTP results in a dose 
reduction of almost 60% compared to a Ceph without shielding (see figure 6). 
The CTP achieved a comparable dose reduction to the classic thyroid shield. 
The dose to the thyroid was reduced by 85% by the CTP, and by 89% by 
the thyroid collar. The differences  between the protocols were all found to 
be highly statistically significant. The dose reduction achieved by the two 
devices together was approximately 5µSv per Ceph. This is very similar to 
the reduction reported in studies using wedge-formed collimation.11,12,13,14,15 
Figure 5 – Drawing of the 
application of the CTP
Figure 6 – 
Lateral cephalogram showing ACC 
and CTP combined.
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It appears that only 40% of the dose of an uncollimated Ceph is required in 
order to arrive at the diagnosis.
STATISTICS
However, in regards to the different exposure protocols, in the dose study of 
Chapter 4 we encountered difficulties in reporting correct confidence intervals 
around our calculated values. There is a certain amount of random error (RE) 
in every experimental measurement. The amount is dependent for example 
in our study on the accuracy of the dosimeters and the stability of the output 
of the X-ray generator used. The dose measurements of the study reported 
in Chapter 4 involved 50 dosimeters at different locations in the phantom 
head. The read out values of these dosimeters contain RE. These values are 
used in a complex calculation to arrive at the effective dose. Because some 
dosimeters are used more than once in the calculation, the mathematical 
calculation of error propagation thus becomes complex. The irradiation 
of the phantom head by the X-ray generator is also prone to RE, as is the 
background correction and also the calibration factor used to redefine the 
read out value of a dosimeter to a dose level. Many published dose studies do 
not report confidence intervals around the calculated effective dose values, 
or give an indication of the accuracy of the dosimeter system used.27,28,29 
Some give unrealistically low confidence intervals for the resulting effective 
dose because the factors contributing to RE are not correctly taken into 
account.30  We wanted to report the correct confidence intervals and so we 
explored the use of statistical software to correctly assess the RE in the dose 
measurement experiment. In Chapter 5 of this thesis we describe how this 
can be done with statistical software R (R version 3.0.2; The R Foundation for 
Statistical Computing, Vienna, Austria). This software was used to introduce RE 
around the measurement values on the basis of Monte Carlo simulation while 
performing multiple calculation cycles. This proved a viable way to correctly 
assess RE and to make credible statements about the statistical significance 
of the differences found between exposure protocols. Modelling a dose 
measurement experiment in statistical software can also be done prior to an 
experiment to help with the power calculation during the design phase of the 
study, for instance to determine how many exposures of the phantom head 
are needed or how many dosimeters per location. This method of assessing 
RE is applicable to dose studies of all kinds of exposure protocols. In our case, 
we tested protocols for Ceph, but it is also applicable to CBCT or panoramic 
dose studies. In fact this statistical method is not limited to dental radiography, 
and can also be used in the medical field when effective dose is calculated in a 
dosimetric study with a phantom.
 We realised that instead of trying to 
collimate the two regions with one device, 
it would be more feasible to shield them 
with two different devices
 95
COST UTILITY ANALYSIS 
Achieving a dose reduction of 5µSv or almost 60% in cephalography by 
the two devices might seem a sensible way of complying with the ALARA 
principle. But the dose level of a Ceph is already low; so does it make sense 
to lower this already low dose? ALARA does not strive to achieve a dose as 
low as possible but rather one that is as low as is reasonably achievable, where 
social and economical factors must be taken into consideration.2 The dose 
reduction has a price in the form of financial costs. What is reasonable and 
how should social and economical factors be taken into account? To answer 
this question, in Chapter 6 we looked for methods to perform a cost-utility 
analysis (CUA). In a CUA one has to compare the value of the dose reduction 
with that of the costs, by expressing both in the same quantity. We explored 
three different methods of approaching the CUA comparing them on the basis 
of criteria of coherence and adaptability. The first method of CUA was using 
the ‘Alpha Value’, a monetary valuation of dose reduction used in the nuclear 
industry. The second method of CUA was using the value of a statistical life 
for the valuation of the reduction in stochastic adverse effects. The third 
method was the time-for-time method based on a theory postulated by N. 
Lind in 2002, which proved to be the most suitable in terms of coherence and 
adaptability.31 This method expresses both the dose reduction and its financial 
costs in an amount of time for comparison. In this method, the reduction 
of the risk has to be expressed as a number of reduced stochastic effects 
using the ICRP risk factor. These stochastic effects again can be converted to 
reduction of lost life time by taking the average number of years that are lost 
per stochastic effect into account. The risk factor and the lost life time per 
stochastic effect can be adjusted for the population the device is used for. The 
financial costs of the dose reduction are also expressed in an amount of time. 
This is done by calculating how much time an average worker has to work 
to earn the amount of money equivalent to the costs of the dose reduction 
measures. This is dependent in turn on the local gross national income per 
capita in the particular economy where the CUA is performed. With these 
data it is possible to calculate with a simple formula how many times the dose 
reducing devices have to be used before they become cost effective: 
n =
c . f
GNIc . ΔSv . RFadj . LLT/SEadj
where  is the minimum number of uses; c is the monetary cost of the device; 
f is the factor of his/her life an average person spends working; GNIc is the 
gross national income per capita; ∆Sv is the amount of dose reduction per 
exposure; RFadj is the risk factor adjusted for the specific patient population; 
and LLT/SEadj is the lost life time per stochastic effect adjusted for the specific 
patient population. 
When the dose-reducing devices ACC and CTP presented in chapter 2, 3 
and 4 are evaluated using the cost utility analysis it can be concluded that the 
devices are cost-effective when used more than 200 to 600 hundred times. 
This number seems quite realistic, given the typical life cycle of orthodontic 
equipment in the orthodontic office. The formula also provides information 
about the limit to the financial outlay on small dose reductions, as it then 
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indicates that an unrealistic high number of uses is needed in order to become 
cost effective. In an orthodontic office where for example 300 cephalograms 
are made per year, the investment starts to pay off after two years of use, 
which is a realistic time for the return on investment. The same kind of 
calculation can be made for dose reducing measures outside the dental 
field. If for example a mammography unit can be upgraded to operate with 
a lower dose, with this formula, on the basis of the dose reduction and the 
average age of the screened population, a credible CUA can be performed. 
Of course there are more factors involved in dose reduction in these instances. 
Comparing the dose with that of other care providers using diagnostic 
reference levels is such a factor. 
It should be noted that this CUA, like any other, is necessarily based on 
certain assumptions. The first is that the inherent logic of the ´time-for-time 
theory´ is in fact correct. This logic postulates that the proposal of measures 
to save lives in fact is consuming lives when the average worker has to spent 
more time working for the costs of the live saving measure than that actual 
lifetime saved. This is a very attractive and convincing postulate. But one could 
argue that this postulate contains the implicit assumption that time spent 
working is something to be judged as negative. Particularly in times where 
mass unemployment is a major social problem, this may not be the case. The 
positive side effects on self esteem and sense of purpose of being employed 
should also be taken into account in this regard. When these considerations 
lead to adjustment of the appreciation of time spent working, the factor f in 
the formula should be reduced. This, according to the CUA, would mean that 
risk reducing measures are becoming cost effective after fewer cycles of use. 
The second assumption this CUA is based on are the ICRP’s principles 
underlying the risk calculations. For example, these principles are founded 
on the theory that a linear relation exists between dose and risk – the so 
called ‘Linear No-Threshold Theory (LNT)’. These assumptions are adopted 
by the ICRP as the basis of the framework of radiation protection because 
they are the best we have given the current state of knowledge and because 
they are prudent. However, there has been criticism in the literature that the 
assumptions of the ICRP are too conservative.32,33 As well, the risk calculations 
contain great uncertainties.34 It is possible that the LNT overestimates the 
radiation risk. However, as long as the prudent radiation protection framework 
of the ICRP is not scientifically rejected its principles can be expected to be 
maintained. 
The disdain with which some researchers approach the ICRP framework 
of radiological protection, with the LNT as an important element, is 
remarkable.35,36 The ICRP (and its predeceasing organisation the IXRPC) 
were formed because of the concerns that governing bodies held about the 
safety of the populace with the increasing application of ionising radiation, 
administered by the medical profession and other groups. The ICRP’s role 
was to disseminate expert scientific knowledge of radiation protection to 
governing bodies and policymakers who could use its advice to regulate the 
use of ionising radiation to protect their populations. Since ionizing radiation 
is potentially hazardous, when medical professionals use it under conditions 
that are not in keeping with the ICRP’s advice as it is reflected in laws and 
regulations, they are in fact not only potentially endangering the general 
health of the population but also undermining the public’s confidence in the 
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medical profession. Certainly the principles of the ICRP can be challenged 
scientifically and, if convincingly proven wrong, changed. However, until this 
happens we should value these principles, as they are our laissez passer for 
safely applying ionising radiation in patient care. 
The application of ionising radiation is made safer for our patients with the 
dose reducing devices, the method for CUA of dose reducing measures, 
and the method of correctly reporting the results of dose studies which are 
introduced in this thesis. To return to the issue of whether or not the majority 
of Cephs are justified; it seems that we accomplish more for the orthodontic 
patient by first reducing the dose of every Ceph by 60% and subsequently 
trying to persuade orthodontists to reduce the number of Cephs, then by the 
other way around.
CONCLUSIONS
–  It is possible to collimate a fixed area above and behind the skull base 
with the anatomical cranial collimator (ACC) on every Ceph, without losing 
diagnostic information. In doing so, the irradiated area of the patient can 
be reduced by approximately one third.
–  With the cephalograhic thyroid protector (CTP) the orthodontic clinician 
can comply with the guidelines by keeping the thyroid gland out of the 
primary beam during cephalography. This is possible without sacrificing the 
possibility of performing a cervical vertebral maturation index, as would 
occur with the alternative of the thyroid lead collar.
–  With two devices (ACC and CTP) the radiation dose in orthodontic lateral 
cephalography can be reduced by almost 60%. 
–  The results of phantom dose studies can be given with credible confidence 
intervals when Monte Carlo simulation is used for the assessment of the 
RE. To do this the dose experiment should be accurately modelled in 
statistical software, taking all sources of RE into account.
–  It is possible to make a well-founded statement about the minimum 
number of uses of a dose reducing measure before it becomes cost-
effective, using a simple formula.
–  The ACC and CTP are cost-effective after a realistic number of 200 to 600 
uses, according to this formula. 
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Röntgenstraling is potentieel 
gevaarlijk voor mensen. Na een 
latentietijd van 6 tot meer dan 20 jaar 
is er een kans dat tumoren ontstaan. 
De grootte van die kans hangt af 
van de hoeveelheid straling die het 
weefsel heeft geabsorbeerd en de 
gevoeligheid van dat weefsel voor 
straling. De schildklier is een van de 
gevoeligste organen in het hoofd-
halsgebied, net als de speekselklieren 
en het rode beenmerg. Verder is het 
zo dat kinderen een grotere kans 
op nadelige effecten hebben dan 
volwassenen.
De stralingsdosis bij een röntgen-
schedelprofielopname (RSP) die in de 
orthodontie veel wordt gebruikt, is 
relatief laag en dus is de individuele 
kans op een nadelig effect ook 
klein. Maar omdat wereldwijd 
heel veel kinderen orthodontisch 
behandelingen krijgen en er dus heel 
veel RSP’s gemaakt worden, maakt 
de verhoogde kans op tumorinductie 
voor de bevolking in haar geheel het 
toch de moeite waard te onderzoeken 
of de stralingsbelasting bij deze 
opname te verlagen is.
Een dergelijke reductie past in 
het grotere kader van stralings-
bescherming zoals dat door de 
gezaghebbende International 
Commission on Radiological 
Protection (ICRP) is geformuleerd. 
De ICRP ziet drie stappen in 
de stralingsbescherming bij 
diagnostische röntgenopnamen, te 
weten: rechtvaardiging, optimalisatie 
en dosislimieten voor de werkers. 
Deze laatste stap blijft hier verder 
buiten beschouwing. 
De eerste stap, rechtvaardiging, wil 
zeggen dat de patiënt meer baat 
moet hebben van de opname dan 
er nadeel van te ondervinden. In 
de literatuur is discussie over de 
vraag of RSP’s het behandelplan wel 
substantieel beïnvloeden. 
Als een opname inderdaad 
gerechtvaardigd is, is de tweede stap 
deze met een zo laag mogelijke dosis 
te maken. Dit is het zogenaamde 
ALARA-principe, waarbij het acroniem 
staat voor As Low As Reasonably 
Achievable (zo laag als redelijkerwijs 
haalbaar). Dit betekent concreet 
dat belichtingstijd, buisspanning en 
buisstroom bij het röntgentoestel op 
de individuele patiënt moet worden 
afgesteld. Ook het gebied dat in 
beeld komt, moet zo klein mogelijk 
worden gekozen, om niet onnodig 
delen van het lichaam te bestralen. 
Wat betreft de RSP viel het eerdere 
onderzoekers al op dat boven 
de schedelbasis en onder de 
onderkaak een groter gebied wordt 
afgebeeld dan nodig. Er zijn maskers 
bedacht die deze gebieden van de 
stralingsbundel afschermen, maar 
die zijn nooit werkelijk in zwang 
geraakt. Mogelijke redenen zijn 
dat de maskers niet op moderne 
apparaten passen en dat het gebied 
onder de onderkaak per patiënt zeer 
verschillend is zodat wanneer een 
vast gebied afgeschermd wordt, het 
masker soms diagnostische informatie 
aan het oog onttrekt, terwijl in andere 
gevallen de schildklier toch nog 
in de bundel ligt. Het lijkt daarom 
praktischer het  gebied boven de 
schedelbasis en dat van de schildklier 
apart af te schermen. In dat kader 
beschrijft hoofdstuk 2 het ontwerp 
van een beschermer voor het gebied 
boven de schedelbasis (de ACC). 
Uit analyse van honderd RSP-
opnamen blijkt de schedelbasis bij 
iedereen ongeveer op dezelfde plaats 
op de opname te worden afgebeeld. 
Dit betekent dat een vast deel van 
het opnamegebied af te schermen 
is, waarbij toch altijd de schedelbasis 
op de afbeelding komt, hoeveel 
anatomische variatie er ook is. Deze 
afscherming verkleint het gebied dat 
bestraald wordt met ongeveer een 
derde. De ACC verstoort bovendien 
de rest van de opname niet. 
Hoofdstuk 3 onderzoekt of de 
ACC de diagnostische informatie 
inderdaad niet in de weg zit. Dat blijkt 
slechts zelden het geval, waarmee 
de kans dat de opname om deze 
reden overgemaakt moet worden, 
verwaarloosbaar is. 
Hoofdstuk 4 beschrijft het ontwerp 
van een innovatieve beschermer 
(de CTP) die de schildklier tijdens 
het maken van de RSP uit de 
stralenbundel houdt. Het al langer 
bestaande alternatief voor de CTP is 
een loodkraag. In de praktijk wordt 
deze weinig gebruikt, waarschijnlijk 
omdat de loodkraag ook de 
nekwervels afdekt. Orthodontisten 
willen de nekwervels op een RSP 
graag zien, omdat de vorm iets zegt 
over de groeispurt en dus over de 
timing bij een beugelbehandeling. 
De CTP beschermt de schildklier, 
maar laat de nekwervels vrij. Het 
is aannemelijk dat daarmee de 
weerstand tegen het beschermen van 
de schildklier weggenomen wordt. Dit 
hoofdstuk gaat verder na in hoeverre 
de ACC en CTP de stralingsbelasting 
voor de patiënt verminderen. Dat 
blijkt bijna 60 procent te zijn. De 
dosis voor de schildklier neemt af 
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met 85 procent. Deze reductie is 
vergelijkbaar met die uit eerdere 
onderzoeken en wat de schildklier 
betreft vergelijkbaar met de prestaties 
van de loodkraag.
Tijdens het dosisonderzoek bleek het 
lastig te zijn om de meetfout goed 
weer te geven in het eindresultaat. 
Met conventionele middelen is dit 
inderdaad moeilijk en veel ander 
onderzoek op dit gebied lijkt 
hier een incorrecte voorstelling 
van zaken te geven. Hoofdstuk 5 
presenteert een oplossing voor dit 
probleem: softwaresimulatie. Die 
blijkt betrouwbare rapportage van 
de meetfout mogelijk te maken. Dit 
is belangrijk, omdat zonder deze 
rapportage een gevonden verschil 
tussen twee opnameprotocollen 
op toeval zou kunnen berusten. 
De softwaresimulatie blijkt ook van 
pas te komen bij het opzetten van 
onderzoek omdat dan duidelijk wordt 
hoe de opzet moet zijn om verschillen 
significant te mogen noemen 
(poweranalyse). 
De gevonden dosisreductie van circa 
60 procent bij het gebruik van ACC 
en CTP lijkt zonder meer de juiste 
weg om aan het ALARA-principe 
te voldoen. De dosis van een RSP 
is echter zo laag dat er wel een 
afweging gemaakt moet worden 
of de kosten om die nog verder te 
verlagen doelmatig zijn. De laatste 
letters van ALARA staan immers 
voor redelijkerwijs bereikbaar, en de 
ICRP voegt daar aan toe ‘sociale en 
economische factoren in beschouwing 
nemend’. De vraag is hoe je dat moet 
doen. 
Hoofdstuk 6 onderzoekt drie 
methoden voor het uitvoeren van een 
kosten-batenanalyse (KBA):
1 Alpha Value (AV)
  AV is een geldelijke waardering 
voor dosisreductie die toegepast 
wordt in de nucleaire industrie. 
2 Waarde van een statistisch leven 
  Dit is een financiële waardering 
van een mensenleven gebruikt in 
risicomanagement.
3 Tijd-voor-tijdmethode
  Deze methode is gebaseerd op de 
stelling dat een risicoreducerende 
maatregel effectief is wanneer de 
gewonnen levensduur in tijd meer 
is dan de tijd die een gemiddelde 
werker moet werken om de kosten 
voor deze maatregel te verdienen. 
De KBA’s werden gebruikt om te 
berekenen hoe vaak een dosis-
reducerende maatregel minimaal 
gebruikt moet worden om 
kosteneffectief te zijn. De methoden 
werden beoordeeld op coherentie 
(worden vergelijkbare resultaten 
gevonden in vergelijkbare landen?) 
en aanpassingsvermogen (kan de 
methode rekening houden met 
leeftijd en geslacht van specifieke 
patiëntengroepen?). De tijd-voor-
tijdmethode, die ook buiten de 
tandheelkunde te gebruiken is, 
voldoet het beste aan de criteria. 
De uitkomst voor ACC en CTP 
was dat deze na 200 tot 600 keer 
gebruik kosteneffectief worden, een 
haalbaar aantal voor de gemiddelde 
orthodontiepraktijk.
CONCLUSIES
Uit dit proefschrift zijn de volgende 
conclusies te trekken: 
–  Bij het maken van RSP-opnamen 
is het bestraalde gebied van de 
patiënt met circa een derde te 
verkleinen door een vast gebied 
boven de schedelbasis met de ACC 
af te schermen.
–  Met de schildklierbeschermer voor 
RSP-opnamen (CTP) houdt de 
behandelaar de schildklier uit de 
primaire bundel zoals de richtlijnen 
vereisen, terwijl de beoordeling 
van de nekwervels voor groei-
inschatting mogelijk blijft.
–  Met de twee hulpmiddelen (ACC 
and CTP) wordt de stralingsdosis 
bij RSP voor de orthodontische 
patiënt met bijna 60 procent 
teruggebracht. 
–  Met softwaresimulatie is de 
meetfout bij dosisonderzoek correct 
te rapporteren.
–  Een kosten-batenanalyse maakt 
gefundeerde uitspraken mogelijk 
over de kosteneffectiviteit van 
dosisreducerende maatregelen. De 
tijd-voor-tijd methode lijkt daarvoor 
de beste benadering. 
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This thesis focuses on possibilities to reduce the dose and thereby 
the carcinogenic risk of orthodontic X-rays. The probability of a tumour 
developing is dependent on the X-ray dose.
The radiation dose to the patient of an orthodontic lateral cephalogram (Ceph) and 
it’s consequential risk is relatively low. Because many children undergo orthodontic 
treatment, and during the course of this treatment usually one or more Cephs are 
made, the consequential collective X-ray burden is considerable, resulting in an 
increase of the incidence of cancer in the population. For this reasons it is worthwhile to 
investigate measures to lower the radiation dose of Cephs, even this dose being already 
comparatively low.
To avoid unnecessary exposure of the population to ionising irradiation, the International 
Commission on Radiological Protection (ICRP) has developed a framework of radiological 
protection principles that has been incorporated into clinical guidelines. This framework 
comprises amongst other the ALARA (‘as low as reasonably achievable’) dose principle. 
This principle leads the clinician to choose exposure parameters and to limit the field of 
view to the area where the diagnostic information is to be found. On Cephs a large area 
above the skull base contains no diagnostic information as well as an area below the 
mandible, where the radiosensitive thyroid gland is found. This has lead to development 
of a thyroid collar and collimators that shield the area above the skull base and below the 
mandible. For different reasons these protective measures did not become widely utilized 
although theoretically they reduce the dose to the patient by more than 50%. It can be 
hypothesized that instead of trying to collimate the two regions with one device, it would 
be more feasible to shield them with two different devices. 
Therefore in Chapter 2 of this thesis an anatomically-formed cranial collimator (ACC) 
for the area above and behind the skull base for lateral cephalography is introduced. 
An outline for this collimator was established in such a way that it collimates a maximal 
area with only a remote chance of blocking anatomical structures that are of diagnostic 
interest. It was designed to be fixed to the ear post of the cephalostat between the X-ray 
generator and the head of the patient. In Chapter 3 of this thesis the ACC was tested in 
an observer study evaluating 100 Cephs made with the ACC. The results showed that 
there was minimal interference of the ACC on the diagnostic value of the cephalography, 
while reducing the irradiated area of the patient by almost one third.
According to clinical guidelines, shielding the thyroid from the primary beam in lateral 
cephalography is mandatory, unless it interferes with the depiction of structures of 
diagnostic interest. When a thyroid collar is used for this purpose it has been shown that 
the bodies of the cervical vertebrae below C2 are not depicted. The depiction of these 
cervical vertebrae assists orthodontic clinicians in calculating the maturation index which 
in turn can help to choose the optimal timing for orthodontic treatment. Therefore in 
Chapter 4 the design of a thyroid shielding device, referred to as cephalographic thyroid 
protector (CTP), is presented which leaves the cervical vertebrae depicted. In this chapter 
a phantom dose study is presented that quantifies the dose reduction to the patient 
when using ACC and CTP. It appeared that the use of these two devices results in a dose 
reduction of almost 60%. The CTP achieved a dose reduction which is comparable to the 
classic thyroid shield.
In regards to the different exposure protocols, in the dose study of Chapter 4 we 
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encountered difficulties in reporting correct confidence intervals around our calculated 
values. It is important to report the correct confidence intervals and therefore the use 
of statistical software was explored to correctly assess the RE in the dose measurement 
experiment. In Chapter 5 of this thesis the use of statistical software R (R version 
3.0.2; The R Foundation for Statistical Computing, Vienna, Austria) for this purpose is 
described. This software was used to introduce RE around the measurement values on 
the basis of Monte Carlo simulation while performing multiple calculation cycles. This 
proved a viable way to correctly assess RE and to make credible statements about the 
statistical significance of the differences found between exposure protocols. The method 
of software simulation also appeared to be useful for power analysis when designing a 
phantom dose research protocol. This method can also be used for any other exposure 
modality than Ceph.
Achieving almost 60% dose reduction in cephalography by ACC and CTP might seem 
a sensible way of complying with the ALARA principle. But the dose level of a Ceph 
is already low; so does it make sense to lower this already low dose when social and 
economical factors are taken into consideration? To answer this question, in Chapter 
6 we looked for methods to perform a cost-utility analysis (CUA). In a CUA one has to 
compare the value of the dose reduction with that of the costs, by expressing both in the 
same quantity. We explored three different methods of approaching the CUA comparing 
them on the basis of criteria of coherence and adaptability. One method, the time-for-
time method, proved to be the most suitable in terms of coherence and adaptability. This 
method expresses both the dose reduction and its financial costs in an amount of time 
for comparison. It appeared to be possible to calculate with a simple formula how many 
times the dose reducing devices have to be used before they become cost effective: 
n =
c . f
GNIc . ΔSv . RFadj . LLT/SEadj
 
where n is the minimum number of uses; c is the monetary cost of the device; 
f is the factor of his/her life an average person spends working; GNIc is the gross national 
income per capita; ∆Sv is the amount of dose reduction per exposure; RFadj is the risk 
factor adjusted for the specific patient population; and LLT/SEadj is the lost life time per 
stochastic effect adjusted for the specific patient population. 
When the dose-reducing devices ACC and CTP presented in Chapter 2, 3 and 4 are 
evaluated using the CUA it can be concluded that the devices are cost-effective when 
used more than 200 to 600 hundred times. This number seems quite realistic, given the 
typical life cycle of orthodontic equipment in the orthodontic office. 
The use of this method is not limited to dental dose reducing measures.
The conclusions that can be drawn from this thesis are:
–  With two devices (ACC and CTP) the radiation dose in orthodontic lateral 
cephalography can be reduced by almost 60%. without losing diagnostic information
–  The results of phantom dose studies can be given with credible confidence intervals 
when Monte Carlo simulation is used for the assessment of the RE in statistical 
software.
–  It is possible to make a well-founded statement about the minimum number of uses of 
a dose reducing measure before it becomes cost-effective, using a simple formula.
–  The ACC and CTP are cost-effective after a realistic number of 200 to 600 uses, 
according to this formula.
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